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DREAM (Downstream Regulatory Element Antagonistic Modulator) is the first reported 
calcium binding protein that directly binds to DNA and affects gene expression. It 
belongs to recoverin sub-family of neuronal calcium sensing proteins that form part of 
EF- hand super-family. Knockout mice, devoid of DREAM protein, exhibit ongoing 
analgesia due to upregulated expression of the prodynorphin gene. DREAM binds to a 
specific DNA silencing element in the prodynorphin promoter called Downstream 
Regulatory Element (DRE) and serves as a transcriptional repressor under basal resting 
conditions. Neuronal stimulation leads to a rise in nuclear calcium, causing Ca++-bound 
DREAM to dissociate from DNA and result in derepression of prodynorphin expression. 
Thus, DREAM may serve as a potentially specific target for effective pain management. 
Understanding the structural determinants of metal binding and DNA recognition by 
DREAM may help in the future rational design of analgesic drugs.  
In this thesis, the calcium and magnesium binding properties of DREAM were studied by 
performing isothermal titration calorimetry (ITC) analysis on wild-type DREAM protein 
and mutants that have each of the functional EF hands disabled for calcium binding. Our 
results show that DREAM binds two Ca++ ions and one Mg++ ion with high affinity. 
Mg++-bound DREAM is stable as a monomer and Ca++-bound DREAM exists as a dimer. 
Calcium binding stabilizes the protein structure and promotes dimerization to control 
calcium-sensitive recognition of DNA targets.  Next, we attempted to map the DNA 
binding residues in DREAM and its oligomerization interface using biophysical and 
functional characterization of chimeric protein constructs generated by swapping specific 
EF-hand motifs of DREAM protein with those of recoverin. Nuclear magnetic resonance 
(NMR), gel-filtration and electrophoretic mobility shift assays were employed for this 
purpose. The results from this study suggest that both the amino and carboxy terminal 
halves of the protein are important for DNA binding and dimerization of DREAM protein. 
All four EF-hands in DREAM appear to participate in the recognition of DNA.  
 
 
STRUCTURAL CHARACTERIZATION OF METAL AND DNA BINDING TO 










Dissertation submitted to the Faculty of the Graduate School of the 
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 













Professor. Douglas Julin, Chairman 
Dr. James. B. Ames, Advisor 
Professor. Sandra Greer, Dean’s Representative 
Dr. Harold Smith 




















© Copyright by   
































To my mentors during graduate study- 
Dr. Masanori Osawa 
Dr. Alexandra Dace 








I would like express my profound gratitude to my advisor Dr. James. B. Ames for the 
support and guidance obtained throughout my graduate study. His cogent scientific 
thinking and articulate verbal and written communication skills are the qualities I hope to 
emulate during the course of my scientific career. 
I sincerely wish to thank my thesis advisory committee members for the duration of my 
graduate study, Drs Doug Julin, Eric Baehrecke, Harold Smith and Bill Higgins for their 
critical evaluation of my work, valuable ideas and support. Special thanks are due, to Dr. 
Leslie Pick and Professor Sandra Greer for their generous understanding and willingness 
to replace Drs Eric Baehrecke and Bill Higgins respectively, on the committee, who had 
to withdraw for my defense due to scheduling conflicts.  
I would like to thank past and present members of the Ames’ lab- Masanori, without 
whose generous guidance and constant encouragement, during the initial phase of my 
PhD, this thesis would have been a distant DREAM; Nobuko, for her kind advice and 
support throughout my study; Alexandra for all the help during the final stages; Jennifer 
Wingard for the enjoyable company. I would also like to thank colleagues at CARB, 
especially members of third floor of CARB-IB, Fred Schwarz and lab members, for 
assistance with using ITC, Zvi Kelman, Harold Smith and their lab members especially 
JaeHo and Antonio, for their helpful discussions during the third floor lab meetings. 
 iii 
Special thanks to Eugene, Buvna and Celia Chen for their help with structural modeling 
and bio-informatics, and Vivek Gopalan for help with MS Word formatting when needed. 
I take this opportunity to thank my parents for all their hard work, sacrifices and prayers 
that were directed towards my success as a human being and in my educational pursuit. I 
thank my immediate family- my brother Kittu, sister Latha and brother-in-law 
Narasimham and everyone in my extended family for being there and praying for my 
success. I thank my friends Subbu, Jinu, Lisa, Ajjai, Chandu, Nandha, Anil and Arun for 
their friendship, support and company, which helped me get through some tough times 
and made the rest enjoyable, during my current stay in the United States. I would like to 
express special and sincere thanks to my cousin Shanker whose support, being my 
roommate and close-confidant, was indispensable during the later stages of my graduate 
study.  
Finally, I would like to acknowledge the super-natural force that drives me towards 
embarking on this journey and pursuing it with diligence and will power.  
 iv 
 
Table of contents 
 
Table of contents ............................................................................................................... v 
Figure Index ................................................................................................................... viii 
Table Index....................................................................................................................... xi 
Abbreviations .................................................................................................................. xii 
Chapter 1: Calcium Signaling and Regulation of Gene Expression ............................ 1 
1.1 Introduction............................................................................................................... 1 
1.2 Calcium as a biological messenger ........................................................................... 1 
1.3 Calcium homeostasis ................................................................................................ 3 
1.4 Intracellular calcium binding proteins ...................................................................... 9 
1.5 Calcium binding motifs........................................................................................... 10 
1.6 Calcium and gene expression.................................................................................. 14 
1.7 DREAM protein and gene expression .................................................................... 16 
1.8 DREAM and pain ................................................................................................... 27 
1.9 Aim and scope of this study.................................................................................... 28 
Chapter 2: Calcium and Magnesium binding to DREAM.......................................... 29 
2.1 Introduction............................................................................................................. 29 
2.2 Materials and Methods............................................................................................ 34 
2.2.1 Expression and Purification of Mouse DREAM-C and Its Mutants................ 34 
2.2.2 Size Exclusion Chromatography...................................................................... 35 
2.2.3 Preparation of Decalcified Protein Solutions................................................... 36 
2.2.4 Mg++ and Ca++ Titration into DREAM-C by ITC............................................ 36 
2.3 Results and Discussion ........................................................................................... 39 
2.3.1 Apo-DREAM-C binds two Ca++ with high affinity......................................... 39 
2.3.2 Constitutive Mg++ binding at EF-2 .................................................................. 44 
2.3.3 DREAM-C has a high affinity Mg++ site ......................................................... 45 
2.3.3 Calcium- and magnesium-induced conformational changes ........................... 46 
2.3.4 DNA Binding by EF-hand mutants.................................................................. 50 
2.3.5 Mechanism of Ca++-sensitive DNA binding.................................................... 51 
Chapter 3: Yeast one-hybrid study to map DNA binding residues in DREAM 
protein .............................................................................................................................. 52 
3.1 Introduction............................................................................................................. 52 
 v 
3.2 Yeast one-hybrid..................................................................................................... 55 
3.3 Materials and Methods............................................................................................ 56 
3.3.1 Yeast strains used in this study ........................................................................ 56 
3.3.2 Plasmid constructs used in this study............................................................... 56 
3.3.3 Yeast transformation........................................................................................ 58 
3.3.4 Yeast media preparation .................................................................................. 60 
3.3.5 Colony lift filter assay...................................................................................... 61 
3.3.6 Test for protein-DNA interaction in the yeast ................................................. 61 
3.4 Results..................................................................................................................... 62 
3.4.1 DRE reporter yeast strains exhibit high background expression under different 
reporter systems ........................................................................................................ 62 
3.4.2 DREAM cannot bind DNA in the one-hybrid: ................................................ 65 
3.5 Discussion ............................................................................................................... 66 
Chapter 4: Probing the DNA binding Site Structure of DREAM Using DREAM-
Recoverin Chimeras........................................................................................................ 71 
4.1 Introduction:............................................................................................................ 71 
4.2 Materials and Methods............................................................................................ 74 
4.2.1 Construction of DRC plasmids ........................................................................ 74 
4.2.2 Expression and purification of wild type and DRC proteins ........................... 76 
4.2.3 Western blotting analysis on DREAM ............................................................ 78 
4.2.4 NMR spectroscopy........................................................................................... 79 
4.2.5 Size exclusion chromatography ....................................................................... 80 
4.2.6 Electrophoretic mobility shift assay................................................................. 82 
4.3 Results and Discussion ........................................................................................... 84 
4.3.1 DREAM-Recoverin chimeras retain stable tertiary structure.......................... 84 
4.3.2 Oligomerization properties of DREAM-recoverin chimeras vs. Ca++............. 85 
4.3.3 Magnesium inhibits dimerization of DREAM in the absence of calcium....... 90 
4.3.4 Head-to-tail Dimerization of DREAM ............................................................ 91 
4.3.5 Recoverin does not bind DNA......................................................................... 93 
4.3.6 DREAM co-purifies with nuclease activity..................................................... 93 
4.3.7 Heterogenous species of DREAM bind differentially to DNA ....................... 97 
4.3.8 Recombinant DREAM-C binds specifically to DRE....................................... 98 
4.3.9 Recombinant DREAM exists in multiple conformational states................... 100 
4.3.10 Transformation of DREAM-DNA binding activity is not salt dependent... 103 
4.3.11 DRE binding activity is associated with recombinant DREAM.................. 104 
4.3.12 Summary of DNA binding experiments ...................................................... 107 
4.3.13 EMSA analysis on DREAM-Recoverin Chimeras (DRC’s) ....................... 109 
4.3.14 Structural Model for DNA binding to DREAM .......................................... 115 
 vi 
4.4 Summary ............................................................................................................... 117 






Figure-1-1: Mechanisms responsible for calcium homeostasis in the cell. ........................ 4 
Figure 1-2: Structures of NADP derived messengers of calcium release........................... 6 
Figure 1-3: Schematic representation of calcium signaling toolkit. ................................... 8 
Figure 1-4: Diagrammatic illustration of calcium co-ordination motifs........................... 11 
Figure 1-5: Binding of mannose at rat MBPsite 2 ............................................................ 11 
Figure 1-6: Calcium-induced structural changes in calmodulin. ...................................... 13 
Figure 1-7: Schematic illustration of regulation of gene expression by calcium. ............ 15 
Figure 1-8: Amino acid sequence alignment of DREAM and the Recoverin family....... 18 
Figure 1-9: Fluorescent EMSA of DREAM-DRE interaction.......................................... 21 
Figure 1-10: Comparison of prodynorphin expression and dynorphin peptide levels in 
wild type and dream -/- mice........................................................................ 24 
Figure 1-11: Tests for pain phenotype in dream -/- mice. ................................................ 25 
Figure 1-12: Behavioral assessment of calsenilin knockout mice. ................................... 25 
Figure 2-1: Illustration of an EF hand motif..................................................................... 29 
Figure 2-2: Ribbon diagram of the main chain structure of DREAM showing the four EF 
hands............................................................................................................. 30 
Figure 2-3: Amino acid sequence in the four EF hands of DREAM................................ 31 
Figure 2-4: Equilibrium calcium binding measurement using titration of 45Ca++ into 
DREAM protein ........................................................................................... 33 
Figure 2-5: Design of a microcalorimeter......................................................................... 37 
Figure 2-6: Isothermal titration microcalorimetric analysis of Ca++ binding to 
apoDREAM-C.............................................................................................. 39 
Figure 2-7: Comparison of Ca++ binding isotherms for DREAM-C and EF-hand mutants
...................................................................................................................... 41 
 viii 
Figure 2-8: Isothermal titration microcalorimetric analysis of Mg++ binding to DREAM-C
...................................................................................................................... 46 
Figure 2-9:  Two-dimensional 15N-1H HSQC NMR spectra of DREAM. ..................... 48 
Figure 2-10: Molecular weight estimation of DREAM-C by size exclusion 
chromatography............................................................................................ 49 
Figure 2-11. Fluorescence Electrophoretic mobility shift assay of DREAM-C/DRE 
interaction..................................................................................................... 50 
Figure 2-12: Schematic representation of calcium-sensitive DNA binding to DREAM.. 51 
Figure 3-1 Electrophoretic mobility shift assay (EMSA) of DREAM devoid of the N-
terminus in the presence and absence of calcium ........................................ 53 
Figure 3-2: Matchmaker One-hybrid system for detecting DREAM-DRE interaction.... 55 
Figure 3-3: Plasmid maps of vectors used in the one-hybrid study.................................. 57 
Figure 3-4: Colony lift filter assay of yeast double transformed reporter strains............. 63 
Figure 3-5:  DREAM does not bind DNA in one hybrid.................................................. 66 
Figure 4-1: Schematic representation describing the generation of DREAM-Recoverin 
chimeras ....................................................................................................... 74 
Figure 4-2: Oligomerization of DREAM as a function of protein concentration on SEC 81 
Figure 4-4: Size exclusion chromatograms of DREAM-C in calcium-free (A) and 
calcium-bound (B) forms ............................................................................. 87 
Figure 4-5: Overlaid size exclusion chromatograms of calcium-free (blue) and calcium-
bound Recoverin .......................................................................................... 88 
Figure 4-6: Overlaid size exclusion chromatograms of calcium-free and calcium-bound 
DRC-I (A), DRC-II (B)................................................................................ 88 
Figure 4-7 : Overlaid size exclusion chromatograms of calcium-free and calcium-bound 
DRC-III (A), DRC-IV (B), DRC-V (C), and DRC-VI (D).......................... 89 
Figure 4-8: (A) Model for head-to-tail DREAM dimer in calcium bound state, based on 
KChIP1 crystal structure [128] .................................................................... 92 
Figure 4-9: EMSA with recombinant recoverin ............................................................... 93 
Figure 4-10: EMSA with Ni-affinity purified DREAM-C to test DREAM-DRE 
interaction..................................................................................................... 95 
 ix 
Figure 4-11: Effect of carrier DNA (salmon sperm DNA) on EMSA with DREAM-C. . 96 
Figure 4-12: EMSA and SDS PAGE with DEAE purified fractions of DREAM-C........ 97 
Figure 4-13: Test for the specificity of DREAM-DNA interaction.................................. 99 
Figure 4-14: Transformation of DREAM protein activity with age. .............................. 101 
Figure 4-15: Western blot of DEAE fractions with Anti-DREAM antibody. ................ 102 
Figure 4-16: Effect of Salt on gel-shift exhibited by DEAE eluted fractions of DREAM-
C. ................................................................................................................ 104 
Figure 4-17: A) EMSA of Ni++-eluates prepared from empty vector (EV) and DREAM-C 
plasmid containing bacterial lysates........................................................... 106 
Figure 4-18: SDS PAGE analysis indicating progress of purification steps .................. 107 
Figure 4-19: Electrophoretic mobility shift assay using pooled DEAE fractions of wild 
type DREAM-C and Dream-recoverin chimeras. ...................................... 111 
Figure 4-20: EMSA (A) and SDS-PAGE (B) diagrams of DRC-I................................. 112 
Figure 4-21: (A) EMSA and (B) SDS-PAGE diagrams of DRC-II................................ 112 
Figure 4-22: (A) EMSA and (B) SDS-PAGE of DRC-III.............................................. 113 
Figure 4-23: (A) EMSA and (B) SDS-PAGE of DRC-IV.............................................. 113 
Figure 4-24: (A) EMSA and (B) SDS-PAGE of DRC-V. .............................................. 114 
Figure 4-25: (A) EMSA and (B) SDS-PAGE of DRC-VI.............................................. 114 
Figure 4-26: Model diagram showing potential assembly of a DREAM tetramer on the 






Table-1-1: Examples of calcium binding proteins in mammalian cells ........................... 10 
Table.3-1: Qualitative results in terms of cell viability in the presence of 3-AT ............. 64 
Table:4-1: Oligonucleotide primers used for generating DREAM-Recoverin chimeras . 79 
Table 4-2: Summary of SEC results ................................................................................. 90 







3-AT - 3 aminotriazole 
ADP - Adenosine di-phosphate 
APS - Ammonium per sulfate 
ATP - Adenosine tri-phosphate 
cADPR - Cyclic adenosine di-phosphate ribose 
cAMP - Cyclic adenosine mono-phosphate 
CAT - Chloramphenicol acetyl transferase 
CREB - Cyclic AMP response element binding protein 
CREM - Cyclic AMP response element Modulator 
CtBP - C-terminal binding protein 
DEAE - Diethyl aminoethyl group 
DNA - Deoxy ribonucleic acid 
DRC - DREAM-recoverin chimeras 
DRE - Downstream regulatory element 
DREAM - Downstream regulatory element antogonistic modulator 
EDTA - Ethylene di-amine tetra-acetate 
ELISA - Enzyme linked immunosorbent assay 
EMSA - Electrophoretic mobility shift assay 
ER - Endoplasmic reticulum 
GCAP - Guanylate cyclase activating protein 
GR - Glucocorticoid receptor 
HCl - Hydrochloric acid 
IP3 - Inositol 1,4,5 tris-phosphate 
ITC - Isothermal titration calorimetry 
KChIP - Potassium channel interacting protein 
LTP - Longterm potentiation 
NA - Nicotinic acid 
 xii 
NAADP - Nicotinic acid adenine di-nucleotide phosphate 
NaCl - Sodium Chloride 
NCS - Neuronal calcium sensor 
NMR - Nuclear magnetic resonance 
PAGE - Polyacrylamide gel electrophoresis 
PDB - Protein data bank 
PLC - Phospholipase C 
RNA - Ribonucleic acid 
SDS - Sodium dodecyl sulphate 
SEC - Size exclusion chromatography 
YPAD media - Yeast extract peptone adenine dextrose media 
 xiii 
Chapter 1: Calcium Signaling and Regulation of Gene Expression 
1.1 Introduction 
Living cells need to communicate with the environment in order to adapt or respond to 
external stimuli. An external stimulus acts as a signal that elicits a specific response from 
the cell. Thus, the external signal is a first messenger that activates a cell’s response and 
the primary component inside the cell that triggers the response is called a second 
messenger [1]. The process of communication between a cell and its external 
environment through stimulus derived intracellular messengers is called signal 
transduction. Intracellular messengers are often small molecules such as cAMP [2] , 
inositol 1, 4, 5, tris phosphate (IP3) [3] and metal ions such as Ca++ [4] and Mg++ [5]. The 
salient feature of a second messenger is that its resting levels in the cell are low and there 
are specific “on” mechanisms that generate the messenger in sufficient amount, in 
response to the stimulus-derived signal, and “off” mechanisms that help in clearing the 
messenger once it has carried out its function. Such “on” and “off” mechanisms help in 
generating the messenger to transmit the signal and clearing it once the signal processing 
is complete  [4], (fig.1-1) and also help in maintaining a steady levels of messenger in the 
cell, also called homeostasis (Greek: homoios: same; stasis: stand [6]). 
1.2 Calcium as a biological messenger  
In 1883, Ringer first attributed a regulatory role for calcium inside the cell (Reviewed in 
[7]). In his classic perfusion experiments with isolated frog heart, he observed that adding 
calcium salts to distilled water keeps the heart beating longer than when in distilled water 
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alone. Ringer’s experiments paved the way for a generation of researchers whose work 
provided compelling evidence that favors the idea that calcium can regulate cellular 
processes and is not merely a structural component being a constituent of bone [8]. L. V. 
Heilbrunn and K Bailey have independently shown that calcium affects the components 
of muscle contraction. Heilbrunn applied calcium to the cut end of a muscle and observed 
a contraction, while K. Bailey discovered that ATPase activity of myosin is promoted by 
calcium but not magnesium ([9], reviewed in [8]). Further evidence from the studies on 
muscle contraction, upon membrane depolarization, also referred as excitation-
contraction coupling [10, 11] and the discovery of calcium transport system in the cell 
[12-14] confirmed the importance of calcium as a signal. The role of calcium in 
excitation-contraction coupling was first demonstrated when isolated muscle fibers 
soaked in calcium free medium do not show a mechanical response upon membrane 
depolarization as against medium containing calcium (discussed in [10]). Furthermore, 
Hasselbach and Makinose observed that isolated vesicles of sarcoplasmic reticulum store 
calcium transported from the surrounding medium in a magnesium and ATP dependent 
manner (discussed in [12]).  
Extending the above mentioned studies, along with several others (reviewed in [15]), 
Howard Rasmussen proposed a second messenger function to calcium [15, 16]. Indeed, 
calcium is shown to serve as second messenger in processes such as egg fertilization [17, 
18], neurotransmitter release [19] and cell death [20]. That calcium is a universal 
signaling messenger was confirmed, from reports that identify calcium in a signaling role 
in bacteria and plants as well. Resting calcium levels in bacteria are in the nanomolar 
range, but increase in cytosolic calcium occurs in response to signals such as starvation 
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[21, 22]. Bacteria also contain calcium binding proteins [23] and calcium transporters 
[24] that maintain calcium homeostasis (see section 1.3). Calcium regulates various 
processes such as cell maintenance, motility, cell division, gene expression and 
sporulation of bacteria  [22, 23]. Several external stimuli such as light, stress and wind 
trigger an increase in cytosolic calcium in plant cells [25, 26]. Thus, calcium plays an 
important role not only as a nutritional requirement, by virtue of its involvement in bone 
growth in animals [27] and cell wall development in plants [28] but also as a signaling 
component [7, 28, 29]. Likewise, in animals, calcium was shown to regulate cellular 
pathways ranging from cell proliferation [30] to cell death [20, 31] and several other 
processes such as motility [32, 33] and secretion [34] in between.  Thus,  the small size of 
Ca++ ion, the presence of well organized transport systems that can transport Ca++ into 
and outside the cell (see section 1.3), and the ability to form coordination complexes with 
varying coordination numbers (six-eight), make calcium an ideal second messenger [7] .       
1.3 Calcium homeostasis 
Cytosolic calcium levels (and nuclear calcium) are determined by a dynamic balance 
between uptake and release processes that transport Ca++ into the cytosol (and cell 
nucleus) from the cell exterior and/or internal stores (e.g. endoplasmic reticulum and or 
related organelles, fig.1-1, 1-3) and vice-versa [4, 35]. In mammals, basal levels of 
cytosolic/nuclear Ca++ are in the nanomolar (10-9 M) range [36, 37] as is the case with 
lower organisms such as yeast [37], compared to milli molar (10-3 M) range in the cell 
exterior and internal stores [38]. The large concentration gradient of Ca++ between 
cytosol and cell exterior is maintained with the help of Ca++-ATPase  pumps that utilize 
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energy in the form of ATP to transport calcium from the cytosol into the ER lumen 
and/or cell exterior [39] (fig (1-1, 1-3).  Various ion exchangers [40] and a mitochondrial 
calcium uniporter [41] also assist in transporting calcium out of the cytosol (fig.1-1, 1-3) 
[4, 42]. Nuclear calcium has been shown to be in equilibrium with cytosolic calcium due 
to its diffusion through nuclear pores [35, 43]. However, recent studies suggest there may 
be an independent signaling network that regulates nuclear calcium levels as well [44, 45]. 
 
 
Figure-1-1: Mechanisms responsible for calcium homeostasis in the cell. Examples of processes controlled 
by calcium-dependent effectors are shown with their respective time scales of occurrence. ER/SR: 
Endoplasmic reticulum/Sarcoplasmic reticulum; PMCA: Plasma membrane Ca++ ATPase; R: receptor; 
SERCA: sarco/endoplasmic reticulum Ca++ ATPase; Ins(1,4,5)P3R: Inositol 1,4,5 tris phosphate receptor; 
RYR: Ryanodine receptor; NCX: sodium calcium exchanger.  (Figure reproduced from [4]) 
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A transient rise in cytosolic/nuclear Ca++ concentration (termed Ca++ influx) occurs in 
excitable cells when ion channels (see [46] for various types of calcium channels) open 
during membrane depolarization [47] or receptor stimulation that generates second 
messengers causing the release of calcium from internal stores (fig. 1-1, 1-3). These 
messengers include inositol 1,4,5-trisphosphate (IP3) [48, 49], sphingosine 1-phosphate 
[50], cyclic ADP ribose (cADPR) [51], nicotinic acid adenine dinucleotide phosphate 
(NAADP) [52] and calcium itself through a mechanism called calcium induced calcium 
release (CICR) [53-55]. IP3 is generated by different isoforms of the enzyme 
Phospholipase C that are stimulated by different kinds of receptors such as G-protein-
coupled receptors (PLCβ), tyrosine-kinase-coupled receptors (PLCγ) (fig.1-3), an 
increase in Ca++ concentration (PLCδ) or activation through Ras (PLCε) (reviewed in [4]). 
A newly identified isoform of PLC, PLCζ was reported to be injected into the egg by the 
sperm and is responsible for Ca++ oscillations during egg fertilization [56]. IP3 mobilizes 
calcium through IP3 receptor, an intracellular receptor that acts as a calcium channel on 
the ER membrane [57] (fig.1-3). Ghosh T. K. and co-workers (1990) have reported that 
sphingosine 1-phosphate, a cellular metabolite derived from ceramide, can also be a 
regulator of calcium homeostasis in mammaliam systems [50]. Later it was confirmed to 
be a regulator of calcium release in yeast and plants [58]. Sphingosine-1-phosphate is 
synthesized with the help of an enzyme sphingosine kinase that phosphorylates 
sphingosine derived from sphingolipids [58] and modulates calcium release from ER 
through a sphingolipid Ca++ release-mediating protein of endoplasmic reticulum 
(SCaMPER) [59] (fig.1-3). 
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Recently two new second messengers, cADPR (cyclic adenosine diphosphate ribose) and 
NAADP (nicotinic acid adenine dinucleotide phosphate), were reported to function in 
increasing calcium levels in the cytosol [60, 61] (fig. 1-2, 1-3). Synthesis of cADPR 
involves cyclization resulting in the formation of an N-glycoside linkage between the 
anomeric carbon of the terminal ribose unit and the N6- amino group of adenine moiety 
and removal of the nicotinamide group. NAADP synthesis involves a base-exchange 
reaction where the nicotinamide group in the substrate, NAD (Nicotinamide adenine 
dinucleotide), is exchanged with nicotinic acid (NA) [62]. Both reactions, synthesis of 
cADPR and NAADP are catalyzed by the same enzyme ADP ribosyl cyclase. While 
cADPR modulates Ryanodine receptor on the ER membrane, NAADP mobilizes calcium 
from the lysosomal reserve granule stores [60] and, through NAADP receptor, from the 
ER (fig. 1-3). 
A.     B.  
Figure 1-2: Structures of NADP derived messengers of calcium release. (A) cADPR (cyclic adenine 
diphosphate ribose) and (B) NAADP (Nicotinic acid adenine dinucleotide phosphate). 
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Cytosolic buffer proteins such as calbindin D-28, Calretinin and parvalbumin (table 1-1) 
sequester most of the calcium thus released resulting in a small fraction of free calcium 
binding to effectors (see section1.4) that activate various downstream processes operating 
over a wide range of timescales (fig.1-1),  [4]. The increase in cytosolic free calcium, 
either slow and sustained  or fast and short-lived, in turn translates into a specific cellular 
output at the level of gene expression [63, 64]. Thus, qualitatively different kinds of 
cytosolic calcium influx can occur due to the nature of the “on” mechanism operating or 
due to synergy of calcium signaling with other signaling pathways mediated by cAMP, 
MAP kinases, nitric oxide synthase (fig.1-3), [65].  
The cytosolic/nuclear Ca++ concentration returns back to its resting level once receptor 
stimulation is turned off.  “Off” mechanisms utilize Ca++-ATPase pumps [39], 
exchangers [40] and a mitochondrial calcium uniporter [41] to clear calcium from the 
cytosol (fig.1-1, 1-3), [4, 42]. The Ca++ ATPases on plasma membrane (PMCA) and 
sarco/endoplasmic reticulum membrane (SERCA) utilize energy in the form of ATP and 
pump calcium to the cell exterior and into the stores respectively [39] (fig.1-1, 1-3). 
Sodium calcium exchanger on the plasma membrane utilizes the sodium gradient across 
the plasma membrane and exchanges three sodium ions to extrude one calcium ion [66] 
(figs.1-1, 1-3). The sodium thus transported into the cell is cleared using the Na+-K+ 
ATP’ase on the plasma-membrane by utilizing energy in the form of ATP [67]. 
Mitochondria has a uniporter that uses the electro-chemical gradient resulting from the 
extrusion of protons and transports calcium into the matrix [42]. Thus, various 
components of calcium signaling form a “calcium signaling tool-kit” [4, 42], (fig.1-3) 
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that orchestrates the transmission of calcium signals and their subsequent removal from 
the cytosol.  
  
Figure 1-3: Schematic representation of calcium signaling toolkit. Cells have an extensive signaling toolkit 
that can be mixed and matched to create Ca++ signals of widely different properties. Ca ++-mobilizing 
signals (blue) are generated by stimuli acting through a variety of cell-surface receptors (R), including G-
protein (G)-linked receptors and receptor tyrosine kinases (RTK). The signals generated include: inositol-
1,4,5-trisphosphate (Ins(1,4,5)P3), generated by the hydrolysis of phosphatidylinositol-4,5-bisphosphate 
(PtdIns(4,5)P2) by a family of phospholipase C enzymes (PLC , PLC ); cyclic ADP ribose (cADPR) and 
nicotinic acid dinucleotide phosphate (NAADP), both generated from nicotinamide-adenine dinucleotide 
(NAD) and its phosphorylated derivative NADP by ADP ribosyl cyclase; and sphingosine 1-phosphate 
(S1P), generated from sphingosine by a sphingosine kinase. ON mechanisms (green) include plasma 
membrane Ca++ channels, which respond to transmitters or  to membrane depolarization ( V), and 
intracellular Ca++ channels — the Ins(1,4,5)P3 receptor (InsP3R), ryanodine receptor (RYR), NAADP 
receptor and sphingolipid Ca++ release-mediating protein of the ER (SCaMPER). The Ca++ released into the 
cytoplasm by these ON mechanisms activates different Ca++ sensors (purple), which augment a wide range 
of Ca++-sensitive processes (purple), depending on cell type and context. OFF mechanisms (red) pump Ca++ 
out of the cytoplasm: the Na+/Ca ++ exchanger and the plasma membrane Ca++ ATPase (PMCA) pumps 
Ca++ out of the cell and the sarco-endoplasmic reticulum Ca++ ATPase (SERCA) pumps it back into the 
ER/SR. (TnC, troponin C; CAM, calmodulin; MLCK, myosin light chain kinase; CAMK, Ca++/calmodulin-
dependent protein kinase; cyclic AMP PDE, cyclic AMP phosphodiesterase; NOS, nitric oxide synthase; 
PKC, protein kinase C; PYK2, proline-rich kinase 2; PTP, permeability transition pore.) (Figure and legend 
reproduced from [42]). 
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1.4 Intracellular calcium binding proteins 
The rise in cytosolic/nuclear calcium concentration during signal transduction triggers a 
variety of downstream signaling pathways mediated by various calcium-binding proteins 
(Table-1-1). Calcium binding to these proteins occurs at a local region of the protein and 
causes global conformational changes that promote its interaction with downstream 
targets. For, example, calcium binding to EF hands of calmodulin (CaM) promotes its 
interaction with diverse targets such as protein kinases (CaM kinases), ion channels 
(calcium-gated K+ channels), and adenylate cyclase due to metal-induced changes in its 
conformation (reviewed in [68, 69]). Calcium bound troponinC activates tropomyosin, 
leading to the exposure of myosin binding sites in the actin filament thereby affecting 
muscle contraction [70]. Calcium binding to the regulatory subunit of the protein 
phosphatase, calcineurin promotes the dephosphorylation of a wide range of protein 
substrates important in neuronal signal transduction [71]. Thus, calcium-binding proteins 
act on a variety of signaling targets and their calcium-induced conformational changes 
are coupled to Ca++-binding motifs that stabilize their structural interaction with 
downstream targets that control a wide variety of processes with different time scales of 






Table-1-1: Examples of calcium binding proteins in mammalian cells (adapted from [36], with ref [72], 
[73], [74], [75]). 
 
1.5 Calcium binding motifs 
To date four kinds of calcium binding motifs have been characterized at the atomic level. 
They are – 1) Annexin domain [76, 77] 2) C2 domain [78-80] 3) C-lectin ([81, 82] and 
fig.1-5) EF-hand domain [83]. The chief difference between these individual structures is 
the way in which the calcium ion is coordinated by the negatively charged amino acid 
side chains of respective proteins (illustrated in figs 1-4, 5). 
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Figure 1-4: Diagrammatic illustration of calcium co-ordination motifs. (A) annexins and (B) C2 domains 
(C) EF hand and (D) gelsolin domain (A & B sourced from PDB website cooresponding to 1axn [84] and 
1uov [85] respectively, C online CaBP data library [86], D adapted from [87]. Pink spheres in A, B and D, 





Figure 1-5: Binding of mannose at rat MBPsite 2: White, grey, and black spheres represent carbon, 
nitrogen, and oxygen atoms; the larger grey sphere represents the Ca-*. A. Co-ordination bonds are shown 
as long dashed lines, hydrogen bonds as short dashed lines. Side chain oxygen atoms of residues 185, 187, 
193, and 205, and the main-chain carbonyl oxygen of residue 206, form the pentagonal, equatorial Ca-* 
ligands. B. This is a view approximately 90° to that of (A), showing van der Waals contacts (short dashed 
lines) between mannose and residues His 189 and ile 207. (figure and legend reproduced from [82] 
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The EF hand motif involves six residues in a 12-residue binding loop that coordinate the 
bound calcium with pentagonal bipyramidal geometry (fig.1-4C). By contrast, the other 
structural motifs contain 4-5 acidic residues that are far apart in linear sequence but are 
positioned close together in the tertiary structure to coordinate the bound calcium ion 
with a variable number of bound H2O molecules. The selectivity of calcium over 
magnesium is because of the difference in solvation energy of these two ions in water [88, 
89] (also see section 2.1). The disparity in the Ca++ coordination geometry, the number of 
bound water molecules and the functional diversity of the respective target proteins 
suggests a convergent evolution of these Ca++-binding motifs. 
A number of calcium binding proteins are targeted to cell membranes in response to 
calcium signaling.  The bound Ca++ structurally bridges Annexin proteins and C2 
domains to the membrane surface [90-92]. In both cases, Ca++ is coordinated on one side 
by residues of the protein and ligated along the opposite direction by a phosphoryl head 
group of the cell membrane. Calcium binding to C-lectins at the membrane surface 
dictates the specificity of carbohydrate recognition that helps in directing processes such 
as endocytosis and cell-cell interactions [82]. EF hand proteins especially those belonging 
to neuronal calcium sensing family, such as neurocalcin, recoverin and guanylate cyclase 
activating proteins (GCAPs) localize to membrane with the help of a myristoylated N-
terminus [93-95]. Additional structural motifs such as parallel β-roll motif [96] and 
gelsolin [87] functionally bind calcium and membranes, in bacteria and mammals 
respectively. Several extracellular proteins with unknown three-dimensional structure, 
such as thrombospondins, fibrinogen, nidogen and integrins are localized to cell 
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membranes and have clusters of glutamate or aspartate rich regions that can bind calcium, 
albeit with weak affinity [72]. 
Most of the calcium binding proteins involved in cell signaling, especially EF hand 
proteins, exhibit high affinity binding to calcium followed by immediate conformational 
changes that allow them to recognize secondary effector molecules such as enzymes, ion 
channels and transcriptional factors (reviewed in [36] [29]). For example, calcium-
induced interaction of calmodulin (CaM) with a variety of enzyme targets such as 
adenylate cyclase [97], phosphodiesterase [98, 99] and calcineurin [100]  modulates their 
activity (reviewed in [101]), thereby affecting the downstream targets that regulate gene 
expression. The calcium-induced conformational changes in CaM lead to rearrangement 
of secondary-structure elements in the protein tertiary structure, thereby resulting in an 
open- form of protein due to exposure of hydrophobic sites that are otherwise buried in 
the apo-form also referred as closed-form (fig.1-6). The calcium-induced exposure of 
hydrophobic residues in the open state promote interaction with hydrophobic segments 
within target proteins and thus many EF-hand proteins such as calmodulin bind and 














Figure 1-6: Calcium-induced structural changes in calmodulin. Figure courtesy: James Ames 
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These calcium-induced conformational changes are highly conserved in all EF-hand 
proteins and are best illustrated in the crystal structures of Troponin C [102], S100 
proteins [103] and solution NMR and crystal structures of Calmodulin [104]. These 
calcium-induced conformational changes mediate cellular response to external stimuli by 
modulating different protein factors and ultimately affecting cellular processes such as 
motility, secretion, cell differentiation, apoptosis and gene expression. 
1.6 Calcium and gene expression 
Calcium regulation of gene expression involves three distinct pathways mediated by 1) 
calcium/Calmodulin dependent kinases (CaM kinases I-IV) [105], 2) calcium-dependent 
protein phosphatase 2A (calcineurin) [71] and 3) calcium-dependent protein kinase C 
(PKC) [106, 107] (Fig.1-6). These individual pathways promote gene expression via 
activation of specific transcription factor proteins.  Increase in cytosolic calcium levels 
activates calmodulin that in turn activates CaM kinases that phosphorylate different 
transcription factor proteins such as CREB, SRF and MEF2 [105]. Direct activation of 
these transcription factors recruit histone acetyl transferases [108] [105], or form hetero-
dimers with other transcription factors of  the Jun family and regulate gene expression . 
Phosphorylation of MEF2 co-repressor protein, Cabin1 [109], by CaM kinase IV 
activates gene expression through de-repression.  In addition, Calmodulin itself binds to 
basic helix-loop-helix (bHLH) transcription factors and directly inhibits gene expression 
[110].  Calcium-induced activation of calcineurin dephosphorylates the transcription 
factor protein, NFAT that in turn is targeted into the cell nucleus where it binds to various 
nuclear partners and activate gene expression [71]. A third pathway involves calcium 
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binding to the C2 domain of PKC that promotes phosphorylation of kappa B kinase that 
phosphorylates the inhibitory subunit of transcription factor NFκB leading to its nuclear 
translocation [106].  
 
Figure 1-7: Schematic illustration of regulation of gene expression by calcium. See text for details. Bold 
arrows represent signal from the periphery. Blue dots represent phosphate. CaM: Calmodulin, CaMKK: 
Ca++/Calmodulin dependent protein kinase kinase, CaMK: CaM kinase, CREB: cyclic AMP response 
element binding protein, SRF: serum response factor, MEF2: myocyte enhancer factor 2, ATF: activating 
transcription factor, CN-A: calcineurin subunit A, CN-B: calcineurin subunit B, NFATc: nuclear factor of 
activated T-cells cytosolic, NFATn: nuclear NFAT, PK-C: protein kinase-C, NFkB: nuclear factor kappa B, 
IkB: inhibitor of kappa B, IKK: IkB kinase, DREAM: Downstream Regulatory Element Antagonistic 
Modulator. Large black block arrows represent external stimulus. 
Other signaling pathways mediated by cAMP and MAP kinase can also affect most of the 
known components involved in calcium signaling. For example, CREB/ ATF family 
transcription factors are also regulated via phosphorylation by protein kinase-A activated 
under elevated levels of cAMP [111]. Furthermore, ATF dependent transcriptional 
activation is also stimulated by activation of mitogen activated protein kinases (MAP 
kinases) which might also be regulated by a CaM kinase cascade [112].  
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An entirely new mechanism of Ca++-regulated gene expression involves the Ca++-binding 
protein, DREAM that modulates transcription by its direct binding to Ca++ and DNA 
targets [74, 113].  DREAM is a 29 kDa transcriptional repressor protein (its full name is 
Downstream Regulatory Element Antagonist Modulator) identified in the brain to bind 
specific DNA sequences (downstream-regulatory-element, DRE) located downstream of 
the promoter of the prodynorphin and c-fos genes [114].  Under normal resting conditions 
(low intracellular Ca++), the Ca++-free form of DREAM binds tightly to the DRE and 
represses transcription (fig. 1-7).  At high Ca++ levels resulting from agonist stimulation, 
Ca++ binding to DREAM leads to its dissociation from DNA targets, promoting activation 
of prodynorphin expression [113].  DREAM is the first reported calcium binding protein 
that directly binds to DNA and regulates transcription [74]. Subsequently however other 
EF hand proteins such as KChIP2 [115] and URE3BP [116] in Entamoeba histolytica 
were also reported to bind DNA and regulate transcription. 
1.7 DREAM protein and gene expression  
DREAM forced a rethinking of our conventional understanding of the link between Ca++ 
and gene expression. DREAM is a 29-kDa protein that belongs to the recoverin 
subfamily of EF- hand proteins that are expressed in the nervous system and function in a 
Ca++-dependent manner. However, proteins such as frequenin are expressed in yeast 
(referred as Ncs1) [117] and DREAM itself is expressed in somatic tissues such as 
pancreas, thyroid gland and testes as well [113, 117]. Apo-DREAM (DREAM without 
bound calcium) was shown to bind DNA elements, called downstream regulatory 
elements (DRE), from the promoters of prodynorphin, c-fos [74], hrk [118] and 
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calcitonin [119] genes. The function of DREAM as a transcriptional repressor was 
interpreted based on the correlation between the DREAM-DNA interaction and increased 
prodynorphin expression in DREAM -/- mice [113]. In addition, the in vivo 
chloramphenicol acetyl transferase (CAT) reporter assays performed by co-transfecting 
plasmids that have DREs, fused upstream of the reporter along with DREAM expression 
vector into neuroblastoma cells showed a decrease in basal expression of reporter gene 
(CAT in this case) indicating a transcriptional repressor function of DREAM [74]. 
DREAM function as a repressor is also established, by correlating calcium induced loss 
of  DREAM-DNA interaction with increased expression of hrk [118] and calcitonin [119] 
and thyroid specific transcription factor genes [120], as observed by increased levels of 
respective proteins on western blots or increased levels of mRNA using northern analysis. 
In addition, DREAM protein also regulates prodynorphin expression in pancreas [120, 
121] and sodium/calcium exchanger NCX3 in hippocampus and cerebellum [122]. 
Biophysical analysis using size exclusion chromatography showed that Ca++ binding to 
DREAM causes changes in the protein oligomerization state [123] which might lead to 
its dissociation from DNA and hence derepression. Furthermore, DREAM was also 
shown to interact, in a two-hybrid system using N-terminus of DREAM as bait, with 
transcriptional co-repressor, C-terminal binding proteins (CtBP’s) and repress 
transcription [124]. Interestingly, DREAM is also shown to act as transcriptional 
activation in conjunction with vitamin-D receptor [125] .  
Sequence alignment of DREAM with other neuronal calcium sensing proteins (NCS 
proteins) across different species, shows that it bears ~45% similarity with respect to the 
EF-hand motifs (Fig.1-8). This level of sequence identity indicates that the main chain 
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three-dimensional structure of DREAM should be very similar to that of recoverin and 
the other NCS proteins.  Indeed, the tertiary structure of the individual EF-hand motifs is 
highly conserved in all EF-hand proteins.  EF- hands are helix-loop-helix motifs that have 
a conserved set of residues in the 12-residue loop, which help in the coordination of Ca++ 
ion [86]. However, depending on the composition of the amino acid residues in the loop, 
the selectivity and affinity towards metal ions can vary. 
 
Figure 1-8: Amino acid sequence alignment of DREAM and the Recoverin family.  Metal coordinating 
loops in EF hands are highlighted in yellow and highly conserved residues are shaded in grey. The proteins 
aligned are human calsenilin/DREAM, mouse calsenilin/DREAM, fly-frequenin, human homolog of 
frequenin, human neurocalcin and bovine recoverin. 
 
Especially the residues in positions 1, 3, 5, 7, 9 and 12 are important in metal-ion 
coordination (fig.1-4C, fig. 2-3). DREAM has four EF- hands and the first EF hand is 
disabled for metal binding as a result of a disruption of the metal binding loop due to a 
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characteristic CPXG sequence (Cys 104 and Pro 105, in fig. 1-8) as seen in the crystal 
structures of other NCS proteins such as recoverin [126], neurocalcin [127] and KChIP1 
[128]. In addition, the second EF-hand in DREAM has an aspartate in the 12th position of 
the loop instead of a glutamate, as in the canonical EF-hand sequence. Studies on chicken 
myosin regulatory light chain show that this substitution, glutamate to aspartate at the 
12th position in the metal coordinating loop of EF hand, would increase selectivity of the 
EF-hand, making it a Mg++/Ca++ site as opposed to Ca++ -specific site [129]. However, 
under physiological conditions (with ~millimolar free Mg++) it is believed that this site is 
constitutively bound by Mg++ and confer structural stability [129]. 
Metal binding to EF-hand motifs causes significant conformational changes (fig.1-6) that 
regulate the function of each of the NCS proteins. The most striking illustration of a 
calcium-induced protein-conformational change was observed in recoverin, a Ca++ 
sensing protein involved in vision [75]. Calcium binding to recoverin leads to the 
extrusion of a buried myristoyl group that is attached to its N-terminus (called as a 
calcium-myristoyl switch), which helps in its membrane localization [75]. However, 
DREAM does not contain a myristoylation signal at its N-terminus. Instead, it is 
characterized by the presence of an additional stretch of residues in the N-terminal region 
(fig.1-8). The similarity in primary sequence of DREAM, notwithstanding the presence 
of an N-terminal tail, to recoverin suggests that the effects of metal binding in DREAM 
protein could be similar to that of Recoverin. Moreover, the C-terminus of DREAM 
(residues 65-256) comprising the four EF hands, is found to be sufficient for DNA 
binding in a Ca++ sensitive manner as removal of residues 1-65 does not affect metal and 
DNA binding properties of truncated protein [130] (fig. 1-9). Furthermore, DNA binding 
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to the N-terminal 1-70 residues (mut1-70) of DREAM polypeptide is calcium insensitive, 
sequence non-specific because DNA binding to mut1-70 persists even in the presence of 
calcium and is equally competed with excess of mutated and non-specific unlabeled DNA, 









Figure 1-9: Fluorescent EMSA of DREAM-DRE interaction. A, EMSA titration of full-length mDREAM 
(0–60μM) into Cy5-labeled DRE (sequence shown-Dynorphin DRE) (5 nM) in the presence and absence of 
10 mM Ca++. The shifted band, corresponding to the ones seen in -Ca++ (arrow), was not detected in the 
presence of Ca++; therefore, only the 60 _M lane is shown. B, EMSA titration of the N-terminal fragment 
(mut1–70) of mDREAM (0–60 μM) into Cy5-labeled DRE (5 nM) in the presence and absence of 10 mM 
Ca++. The shifted band, corresponding to the ones seen in –Ca++ (arrow), was also detected in the presence 
of Ca++ (only the 60 μM lane is shown). C, EMSA titration of the C-terminal fragment (mut65–256) of 
mDREAM (0–70 μM) into Cy5-labeled DRE (5 nM) in the presence and absence of 10 mM Ca++. The 
shifted band, corresponding to the ones seen in –Ca++ (arrow), was not detected in the presence of Ca++ 
(only the 70 μM lane is shown). For competition EMSA, (D) 40 μM wild type mDREAM, (E) 10 μM 
purified mut1–70, and (F) 80 μM purified mut65–256 were incubated with 5 nM Cy5-labeled DynDRE. 
(D) 75 nM (15-fold excess), (E) 325 nM (65-fold excess), and (F) 75 nM (15-fold excess) of unlabeled 
DynDRE, DREmut5, DREmut4, or cAP-1 were added to the same sample as the control lane, respectively. 
In DREmut4 G10 and T11(represented in bold) are mutated to A10 and A11 respectively. In DREmut5 
G10 (represented in bold) in DRE is mutated to A10. (Figure and legend sourced from [130]). 
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Calcium binding to DREAM affects its interaction with protein targets as well. Ledo F. 
and colleagues (2002) [131] have shown that in the absence of Ca++, DREAM physically 
interacts with CREB, disrupts CREB-CRE interaction and thus inhibits CRE (cAMP 
Response element) mediated transcription using co-immunoprecipitation experiments, 
EMSA and in vivo reporter assays respectively. Presence of calcium abolished DREAM-
CREB interaction and led to increased reporter gene expression [131]. DREAM was also 
identified as a binding partner to presenilins and voltage-gated potassium channels in two 
hybrid screens that used C-terminal 103 amino acid residues of Presenilin2 (PS2) [132]  
and the N-terminal 180 residues of rat Kv4.3, Kv4.2 subunits [73] as baits respectively. 
However, the same protein, DREAM was variously named as Calsenilin and KChIP3 
(Potassium channel interacting protein) respectively in these studies.  Calsenilin/DREAM 
regulates the proteolytic processing of presenilins and may potentiate presenilin-induced 
apoptosis and is involved in Alzheimer’s disease pathology [133-136].  
Calsenilin/DREAM also reverses the presenilin-mediated enhancement of Ca++ signaling 
[137]and serves as a substrate for caspase-3 [137]. The KChIP3 protein (identical in 
sequence to Calsenilin/DREAM) binds tightly to Kv4.2 channels and activates channel 
kinetics only at high Ca++ levels [73]. Furthermore, it was shown in thyroid cells that a 
dominant negative mutant of DREAM, which is unable to bind calcium,  affects cell 
cycle progression by delaying the expression of cyclin D3 through an uncharacterized 
mechanism [138]. Thus a single protein variously named Calsenilin/DREAM/KChIP3 
performs different functions in different cellular compartments much akin to other 
multifunctional transcriptional activators such as β-catenin [139] and p53 [140]. Most of 
the localization studies found DREAM to be localized on membranes predominantly 
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[136] - supporting both Calsenilin and KChIP3 functions. But Zaidi et al. (2004) [141] 
have shown that Calsenilin/DREAM translocates into the nucleus in response to increase 
in cytosolic calcium levels. However, Ca++ binding to DREAM is not essential for 
nuclear localization, as mutant DREAM unable to bind calcium also localizes in the 
nucleus when cytosolic calcium levels increase [141]. This could mean that DREAM 
enters the nucleus in apo-form probably because the rise in Ca++ level is insufficient to 
promote calcium binding to DREAM but sufficient to activate another calcium dependent 
factor that might assist in DREAM’s translocation. Details regarding the mechanism of 
DREAM translocation into the nucleus are still unclear. 
The finding that DREAM binds Ca++ was initially surprising because DRE was originally 
identified in the screen for promoter elements involved in PK-A dependent regulation of 
prodynorphin gene [114]. However, DREAM does not contain PK-A phosphorylation 
sites. This apparent paradox was resolved when it was shown that DREAM interacts with 
PK-A phosphorylated α-CREM (cAMP responsive element modulator) and derepresses 
transcription [142]. In this study [142], it was shown that DREAM and α-CREM are 
involved in a two-site interaction that is mediated by a leucine charged domains and a 
leucine zipper in both the proteins. Transcription of prodynorphin in rat is controlled by 
five regulatory elements distributed along the 2kb stretch of the promoter region [114]. 
The distal region of promoter has three CRE’s (cAMP responsive elements) and the 
proximal region has a non-canonical AP-1 site and DRE. DREAM is also shown to 
interact with CREB via the leucine charged domain and repress CRE-mediated 
transcription at low Ca++ levels [131]. This single site interaction involves a leucine 
charged domain and is disrupted at high Ca++ levels leading to derepression. It is well 
 23 
known that mutual negative interference between different transcription factors through 
direct interaction also could lead to transrepression [143]. For example activity of CREB, 
NF-κB, and Oct1 transcription factors is attenuated by direct protein-protein interaction 
with glucocorticoid receptor (GR) [143, 144]. Thus DREAM presents a convergence 
point for PK-A and calcium mediated regulation of prodynorphin expression.  
Cheng et al.(2002) and Lilliehook et al. (2003) independently generated transgenic mice 
that are devoid of DREAM (dream -/- mice) and observed no general behavioral or 
learning disabilities (using rotarod and Morris watermaze tests) in the knockout mice 
when compared to wild type littermates [113, 145]. This means that the knockout mice 
were indistinguishable from wild type mice except for the specific phenotypes observed 
in either study. Cheng et al. observed elevated levels of prodynorphin expression and 
higher levels of dynorphin peptides in dream -/- mice, when compared with wild type 
mice [113] (fig.1-10), that supports DREAM’s transcriptional repressor function as 
reported in [74].  
A.     B.   
 
Figure 1-10: Comparison of prodynorphin expression and dynorphin peptide levels in wild type and dream 
-/- mice. (A) Basal expression of prodynorphin in wild type (+/+) and knockout (-/-) mice assessed by 
semiquantitative RT-PCR. The curves represent the relative abundance of prodynorphin PCR product in the 
two genotypes. (B) ELISA quantitation of spinal dynorphin A(1–17) and dynorphin A(1–8) levels in wild type 
(n = 5) and dream -/- (n = 5) mice 3 hr following intrathecal administration of the peptidase inhibitors, p-
hydroxymercuribenzoate (8 nmol) and phosphoramidon (4 nmol). Triple asterisk indicates p < 0.001 versus 
wild type (two-tailed Student’s t test). Figure and legend sourced from [113]. 
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Moreover, dream -/- mice show a striking phenotype of ongoing analgesia, i.e. lack of 
pain upon application of noxious stimuli such as tail-flick test, intra peritoneal injection 
of MgSO4 and acetic acid (fig.1-11) [113]. Lilliehook et al. observed similar results in the 
tail-flick test in their knockout study but, surprisingly, found that the threshold current 
required for exhibiting escape behavior (running and vocalizing) in the shock-sensitivity 
tests was much lower [145] (fig.1-12).  
A. B. C.  
Figure 1-11: Tests for pain phenotype in dream -/- mice. (A) Tail-flick test in wild type and dream -/- mice. 
Values represent the latency (s) to tail flick from the heat source. Triple asterisk indicates p < 0.001 versus 
wild type (two-tailed Student’s t test). (B and C) Visceral pain in response to (B) MgSO4 (120 mg/kg) or 
(C) acetic acid (0.6%). Values represent the number of abdominal stretches (writhes). n = 8–12 for each 
group. (B) Triple asterisk indicates p< 0.001 versus wild type. (C) Double asterisk indicates p < 0.01 versus 
wild type. Figure and legend sourced from [113]. 
 
 
A.      B.  
 
Figure 1-12: Behavioral assessment of calsenilin knockout mice. A, Tail-flick test. Values represent 
latency to withdraw tail. B, Shock sensitivity. Values represent percentage of maximum shock level (0.08 
mA) required to elicit two stereotypical behavioral responses, running and vocalizing. All data are 
presented as mean +/- SEM, and p values were calculated using the Student’s t test. Wild-type mice (WT), 




However, while researchers in both the studies did not observe any difference in 
expression of presenilins between wild type and knockout mice (as observed by western 
blots), decreased levels of amyloid beta peptides in calsenilin knockout mice as compared 
to wild type (using ELISA quantification) were reported by Lilliehook et al. (2003). 
While Cheng et al. found reasonable expression of DREAM in the spinal cord (as 
observed by western blots), Calsenilin knock out is said to have no detectable DREAM 
expression in spinal cord (using β-gal marker). The authors of the Calsenilin knockout 
study attribute this difference to a possible expression of Calsenilin in very low quantities 
in spinal cord and low sensitivity of β-gal marker as test for protein expression levels.             
In order to assess the effect of knocking out DREAM protein on its KChIP function each 
group followed a different approach. Cheng et al. measured heart-to-body mass ratio and 
assessed heart function using echocardiographic analysis to correlate the knockout 
phenotype with loss of KChIP3 function. Previous studies on transgenic mice 
overexpressing dominant negative Kv4.2 showed enlargement of heart by 10-16 weeks of 
age leading to cardiac failure and death [146]. Similarly, studies on KChIP2 -/- mice 
showed alterations in potassium current resulting in increased susceptibility to cardiac 
arrhythmias [147]. In terms of heart morphology, function and contractility dream -/- 
mice were indistinguishable from their wild type littermates [113]. However, it must be 
noted that the only KChIP natively expressed in heart is KChIP2 and DREAM is exactly 
identical to KChIP3 [73]. In this regard, the calsenilin knockout study attains significance, 
as Lilliehook et al. correlate long-term potentiation (LTP) with A-type potassium currents 
in brain slices of wild type and knockout mice. The authors observe that the knockout 
mice exhibit increased LTP and decreased A-type potassium currents as compared to the 
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wild type. Long-term potentiation is a phenomenon of long lasting synaptic enhancement 
upon repetitive activation of excitatory synapses [148]. Thus, the authors surmise that 
loss of transient outward A-type potassium currents, which are essential to oppose 
membrane depolarization and excitability [149] might be the reason for increased LTP in 
the knockout mice. Thus, the two independent knockout studies complement each other 
in terms of the characterization of the effect of knockout on various functions of DREAM 
protein. In summary, the two knockout studies of DREAM protein combined, provide 
evidence for DREAM’s multi-functionality as calsenilin, DREAM and KChIP3. Further 
reports on additional characterization of these knockout mice are still awaited. 
1.8 DREAM and pain   
Since the DREAM knockout study (see section 1.7) specifically showed elevated 
prodynorphin levels concomitant with ongoing analgesia, this protein might be an 
interesting target for effective pain management. Dynorphin is an endogenous opiate that 
acts through κ opioid receptor. Increased biosynthesis of prodynorphin is observed under 
various conditions associated with neuropathic pain. Although opioid anti-  nociceptive 
property during inflammation is believed to be mediated via µ- opioid receptor, µ- opioid 
receptor agonists such as morphine have been ineffective during neuropathic pain [150]. 
Moreover excessive administration of µ-agonists leads to addiction, tolerance and 
withdrawal [151]. Further dynorphin was shown to inhibit the release of substance-P in 
the spinal cord in a κ opioid receptor mediated manner [152]. Although the actual 
mechanisms of pain manifestation and its eradication are quite complex and still not 
completely understood, since DREAM is thought to influence the pain pathway by 
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regulating the expression of prodynorphin gene it would present an interesting possibility 
of being a therapeutic target.  
1.9 Aim and scope of this study  
My current study on DREAM protein aims to characterize its molecular structure and 
functional relationships. Specifically, since DREAM contains four EF hand calcium 
binding motifs it is essential to know the binding potential of these binding sites and their 
effect on the protein structure. Furthermore, there is limited knowledge about the region 
of DREAM protein involved in DNA recognition. Hence, this study aims to identify the 
DNA binding regions using a high throughput yeast one-hybrid screen and an in vitro 
approach using chimeric protein constructs that have individual and combination of EF 
hand motifs in DREAM swapped with those of recoverin. The rationale is that the main 
chain structures of recoverin and DREAM are likely to be similar due to their high 
sequence identity.  Therefore, substituting individual EF-hand motifs from recoverin 
should not perturb the overall three-dimensional structure.  However, since recoverin 
does not bind DNA and has different metal binding properties, substitution of DREAM 
EF hands with that of recoverin might abolish DNA binding without destroying the 
overall main chain fold and therefore identify the DNA binding surface on DREAM. 
Thus, understanding the metal binding properties and their effect on the protein structure 
as well as the structural determinants of DNA recognition in DREAM protein could 




Chapter 2: Calcium and Magnesium binding to DREAM  
 
2.1 Introduction 
DREAM protein was identified as a transcriptional repressor that can integrate Ca++ and 
cAMP signals [74, 142]. The novel aspect of DREAM protein is that it is the first 
reported calcium-sensor that binds DNA and regulates gene-expression [74]. Calcium 
binding to DREAM is shown to be a key determinant in its interaction with protein [131] 
and DNA [74] targets.  
A.                             B. 
 
Figure 2-1: Illustration of an EF hand motif (for description see text). (A) Figurative description, and 
secondary structure representation (B). (A) was sourced from [153] and (B) was sourced from [154]. 
 
 DREAM contains four EF hand (fig.2-1, 2) calcium-binding motifs similar to those in 
calmodulin [155] and troponinC [102]. The four EF hand motifs share > 45% identity 
with those of recoverin and other members of neuronal calcium sensor (NCS) family of 
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proteins part of the EF hand super-family. While all the members of the NCS family, 
share similar sequence identity in the 12-residue loop region, the inherent metal 
 
 
Figure 2-2: Ribbon diagram of the main chain structure of DREAM showing the four EF hands. The 
structure was modeled based on previous crystal structures of recoverin and neurocalcin. Figure courtesy: 
James Ames. 
 
binding selectivity and affinity of each EF hand and the metal-binding induced effects on 
the protein oligomerization are markedly different. Metal binding was shown to influence 
the oligomerization status and target interaction of some of the NCS family proteins that 
would turn out to be a key determinant of their function. For example, KChIP1 [128] and 
neurocalcin [127] are shown to exist as dimers in Ca++ bound form whereas GCAP2 
[156] exists as dimer in Ca++-free state. DREAM, however was shown to bind DNA as a 
tetramer [74, 130] and upon Ca++ binding dissociates DNA and exists as a stable dimer 
[123] .  
While EF hands of NCS proteins comprise of non-binding, Ca++/Mg++-binding and Ca++ 
selective binding sites, different NCS proteins exhibit different oligomerization properties 
upon metal binding. For instance, the sequence CPXG (figs.1-8, 2-3) in the first EF hand 
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of most of the NCS family proteins disables calcium binding as seen from the studies of 
Muralidhar et al. (2004) on peptides corresponding to the four EF hand motifs in 
Neuronal calcium sensor-1 protein (Ncs1) [157]. Presence of unfavorable residues in a 
key metal coordinating position (position 3 in the EF hand loop, figs.2-3, fig.1-4C) was 
cited as the reason for this disability. Drake et al. (1997) [158]specifically studied the 
contribution of coordinating side chain at loop position 3 [158, 159], using various 
mutants of E. coli galactose binding protein as model for the EF-loop and reason that 
presence of cysteine at loop position 3 leads to loss of Ca++ binding[158].  Lack of metal 
binding to the first EF hand, which contains the CPXG sequence in its loop, is also 
confirmed from the crystal structures of Recoverin [126], neurocalcin [127], frequenin 
[135] and KChIP1 [128].  
 
Figure 2-3: Amino acid sequence in the four EF hands of DREAM. Residues circled in red denote the 
position mutated in the protein for this study and the respective mutations depicted across the circled 
residue. Figure courtesy: James Ames. 
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The second EF hand in DREAM (figs. 1-8, 2-3) has an aspartate instead of the usual 
glutamate residue in the 12th position of the calcium-binding loop. The presence of an 
aspartate in the 12th position increases the selectivity of the EF hand to bind magnesium 
as compared to calcium under physiological conditions [129]. This is because the shorter 
side chain of Asp favors the mono-dentate coordination of Mg++ as opposed to bidentate 
coordination of Ca++ [158, 160] (also fig.1-4C). The selectivity of an EF hand towards 
calcium or magnesium is determined by the composition of amino-acid residues in the 
12-residue loop [158, 160-162]. Furthermore, considering the fact that the resting levels 
of magnesium in the cell are close to 10-3M [163], the ability of an EF hand to bind 
magnesium as well [129] adds another level of regulating these proteins in terms of 
structural changes upon metal binding. While free Mg++ levels are shown to change in 
response to stimulation by neurotransmitters such as glutamate [5] the effect of changing 
[Mg++] on the function of NCS proteins is largely speculative. Many NCS proteins and 
other EF hand proteins, however, functionally bind magnesium and exhibit magnesium 
induced conformational changes [162, 164, 165] . Some proteins, for e.g. parvalbumin, 
show similar effects on protein conformation upon binding calcium or magnesium as 
observed by tryptophan fluorescence emission and ultra violet differential spectroscopy  
[166, 167]; while VILIP and NCS1 proteins show quite different effects as observed by 
tryptophan fluorescence emission [164].  
Magnesium binding to NCS proteins helps in modulation of Ca++ sensitivity of EF hands 
and changes in protein-conformation that affect their interaction with downstream targets  
[168, 169]. Furthermore, increase in free Ca++ levels was shown to result in the 
displacement of Mg++ in GCAP1 [168]. However, direct binding measurements, aimed at 
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determining the metal binding stoichiometry of DREAM, show that DREAM binds, at 
saturation, three calcium ions in the absence of Mg++ ([130], fig.2-4) and two calcium 
ions in the presence of Mg++ (James Ames unpublished observation, fig.2-4). This means- 
out of the four EF hands, while the first hand is disabled for Ca++ binding due to 
unfavorable residues in the first EF hand (see above), one more EF hand is unable to bind 
Ca++ because of the presence of Mg++. Thus, it is unlikely that Ca++ will displace Mg++ 
that is bound to EF-2 of DREAM, under normal physiological conditions (low Ca++ and 
high Mg++) (fig.2-4), which is corroborated by the ITC experiments that involved titration 




Figure 2-4: Equilibrium calcium binding measurement using titration of Ca  into DREAM protein45 ++ . The 
number of ions bound/protein is plotted versus the free calcium concentration. The actual method is 
described in [130]. DREAM1-256: full-length DREAM protein, DREAM65-256: truncated DREAM 
protein devoid of N-terminal 1-64 residues (used in the present study), Hollow squares and crosses 
represent titration of 45Ca++ into full-length and truncated DREAM protein respectively, in the absence of 
Mg++. Dark circles represent titration of 45Ca++ into full-length DREAM protein in the presence of 5 mM 
Mg++. Figure courtesy James Ames. 
 
 33 
Thus, motivated by prior metal-binding studies on NCS proteins (see above) and earlier 
studies on DREAM from the lab (fig.2-4), I set out to characterize in more detail the 
specific binding energetics of both Mg++ and Ca++ to each of the individual EF-hands of 
DREAM protein. For this purpose, DREAM mutant constructs that have the 12th residue 
in the EF hand metal-binding loops of EF-2, EF-3 and EF-4 mutated (shown in fig-2-3) 
were obtained from Mitsu Ikura lab and soluble recombinant proteins were expressed in 
Escherichia coli. The expressed proteins were purified and used for performing 
isothermal titration calorimetry and gel filtration experiments. While I performed the ITC 
of magnesium binding to apo-form and calcium binding to magnesium-loaded form of 
DREAM, the rest of the work described in the metal-binding study was done in 
collaboration with Masanori Osawa, who performed the ITC and gel-filtration 
experiments while training me in protein purification methods. 
2.2 Materials and Methods 
2.2.1 Expression and Purification of Mouse DREAM-C and Its Mutants 
A deletion mutant of mouse DREAM (residues 65–256, named DREAM-C) was shown 
previously to exhibit functional binding to DNA and Ca2+ [130]. The recombinant His-
tagged DREAM-C protein was expressed in soluble form and was purified in milligram 
amounts as described previously [130]. cDNAs encoding wild-type DREAM-C and its 
mutants D150N, E186Q, and E234Q, inserted into pET15b (Novagen) expression vectors 
at NdeI and XhoI sites were obtained from M. Ikura’s lab. These constructs were 
transformed into Escherichia coli BL21(DE3) (Stratagene) cells and were grown in 2 
liters of LB medium with 100 µg/ml ampicillin at 37 °C. Recombinant DREAM-C 
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protein expression was induced by adding 0.5 mM isopropyl 1-thio- -D-galactopyranoside 
to the cell culture once the cell culture reached an optical density of 0.5 at 600 nm, and 
the cells were then grown with shaking at 37 °C for 3 h or 16 °C overnight for the 
mutants. Cells were harvested by centrifugation and resuspended in buffer A (20 mM 
Tris·HCl, pH 8.0, 0.3 M NaCl, 1 mM -mercaptoethanol, and 20% glycerol) supplemented 
with 1 mM phenylmethylsulfonyl fluoride, 0.2% Tween 20, 20 µg/ml DNase I, and 5 mM 
MgCl2. Cells were then disrupted by sonication, and soluble protein fractions recovered 
by centrifugation were applied onto a nickel-loaded Hi-Trap chelating column on an 
AKTA purifier (Amersham Biosciences), previously equilibrated with buffer A. After 
washing with the buffer A (until A280 < 0.01), proteins were eluted with buffer A 
containing 0.3 M imidazole. The eluted solution was dialyzed against buffer B (10 mM 
Tris·HCl, pH 7.4, 1 mM EDTA, and 1 mM dithiothreitol) for 12 h. The dialyzed sample 
was applied onto a Hi-Trap DEAE-FF column (Amersham Biosciences) previously 
equilibrated in the buffer B, and eluted with NaCl gradient (0 to 0.3 M NaCl over 3 h) at a 
flow rate of 5 ml/min. Thus, the recombinant proteins were used for subsequent 
experiments without the cleavage of His-tag, because Ca++ or Mg++ binding to His-tag 
was shown to be negligible [170] and the presence of His-tag does not affect DREAM’s 
interaction with DNA [130]. 
2.2.2 Size Exclusion Chromatography 
Determination of the molecular weight of the purified DREAM-C in solution was carried 
out on a Superdex 200 HR 10/30 column (Amersham Biosciences) at 4 °C in the buffers 
containing 10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol, and 
5 mM CaCl2 for Ca2+-DREAM-C, or 1 mM EGTA for Mg2+-bound DREAM-C. 0.1 ml of 
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DREAM-C (protein concentration ranged from 10 to 460 µM) was loaded onto the column 
and eluted at a flow rate of 0.5 ml/min. Apparent molecular weights were calculated 
using a standard curve of Ve/Vo versus the log of the molecular masses of standard 
proteins: -amylase (200 kDa), alcohol dehydrogenase (150 kDa), transferrin (81 kDa), 
carbonic anhydrase (29 kDa), and myoglobin (17 kDa). Vo is a void volume obtained 
using blue dextran (2000 kDa), and Ve is a volume of elution. 
2.2.3 Preparation of Decalcified Protein Solutions 
In order to obtain accurate measurement of calcium-binding energetics it is essential to 
have the protein in apo-form with no contamination of Ca++ in the buffers. Hence, all the 
buffers used for ITC were decalcified using Chelex 100 resin (Bio-rad). Decalcified ITC 
buffer (150 mM NaCl and 10 mM Tris-HCl, pH 7.6) was prepared by treatment with 
Chelex 100 resin (Bio-Rad). 1 mM dithiothreitol and 5 mM MgCl2 were added after 
treatment with Chelex 100 and immediately before use. Containers and pipette tips were 
rinsed with 1 M HCl twice followed by a rinse with decalcified buffer. EDTA was 
removed from protein solution using Econo-Pac 10 DG gel filtration column (Bio-Rad 
Laboratories, Inc.) pre-equilibrated in 50 ml of the decalcified buffer. Before the ITC 
experiment, the sample cell and injection syringe of ITC machine (Microcal Inc.) were 
cleaned by the decalcified buffer extensively. 
2.2.4 Mg++ and Ca++ Titration into DREAM-C by ITC 
Binding of Mg++ and Ca++ to DREAM-C was measured by ITC [171], using a MicroCal 
VP-ITC MicroCalorimeter (MicroCal Inc.). The protein solution used in the titration was 
exchanged with decalcified buffer using Econo-Pac 10 desalting gel-filtration column as 
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described above. Stock solutions of MgCl2 and CaCl2 (0.5–2.0 mM), used as the titrant, 
were prepared using decalcified buffer as a diluent. A stock solution of CaCl2 with 5 mM 
MgCl2 was the titrant for Ca++ titration of Mg++-bound DREAM-C. The experimental set 












Figure 2-5: Design of a microcalorimeter. A sample (S) and a reference (R) cell are enclosed within an 
adiabatic shields and are connected with coils represented by the pink triangle so that they can exchange 
heat among themselves. The reference cell is maintained at constant temperature using a power circuit. 
During the experiment the reference cell contains the buffer used to solubilize the macromolecule where as 
the sample cell contains the solution containing the macromolecule. As the ligand is injected using the 
syringe the heat change is communicated to the reference cell through the coils (pink triangle) and a 
positive or negative feedback is generated if heat is absorbed or evolved respectively, which is reflected in 
the raw data. 
A typical ITC experiment was performed at 25 °C on a protein solution (1.38 ml, 35–100 
µM) by adding a total of 290 µl of concentrated MgCl2 or CaCl2 (0.50–2.0 mM) in 29 
aliquots (10 µl each). The additions were 3 min apart to allow heat accompanying each 
increment to return to baseline prior to the next addition. For each addition, the molar 
heat (Qt) was measured as a function of total ligand concentration (Xt), 
      Qt = n* Mt* ΔH * V {1+Xt/ (n* Mt) +1/ (n* Ka* Mt) –  
                       [(1+ Xt/ (n* Mt) + 1/ (n* Ka* Mt)2 – 4 Xt/ (n* Mt)] 1/2}/ 2  .. Eq.1 
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where n is the number of sites, Mt is the total protein monomer concentration, where ΔH 
is the molar heat of ligand binding, Ka is the metal-binding association constant (1/Kd), 
and V is the cell volume. The differential molar heat (dQt) measured in the ITC 
experiment was fitted by various binding models (sequential versus independent sites) 
using a nonlinear least squares minimization method [171, 172]. Thermodynamic 
parameters in the analysis are defined by,  
ΔGo = ΔHo- TΔS o                ... Eq.2  
Where ΔGo, Δ Ho and ΔSo are the free energy, enthalpy, and entropy change for single 
site binding and 
ΔGo = - nRT ln(Ka)             ... Eq.3 
where n is the number of moles, T is the absolute temperature, and R = 8.3151 J mol-1 K-1.  
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2.3 Results and Discussion 
2.3.1 Apo-DREAM-C binds two Ca++ with high affinity 
ITC was used to analyze the binding energetics of metal binding to protein (fig-2-6). 
Calcium binding to metal-free DREAM-C (apo-DREAM-C), in the absence of 
magnesium,  shows a multi-phasic isotherm that could be fitted by the binding of three or 
more Ca++ ions, consistent with previous binding studies [130, 173].  
 
 
Figure 2-6: Isothermal titration microcalorimetric analysis of Ca  binding to apoDREAM-C++ . Trace of the 
calorimetric titration of 29 x 10-µl aliquots of 1.3 mM CaCl2 into the cell containing 46 µM apo-DREAM-
C (A), and integrated binding isotherm (B). No correction was needed for the heat of dilution, because 
negligible heat was observed when adding aliquots of CaCl2 (or MgCl2) into a decalcified buffer blank. 
(figure and legend reproduced from [123]) 
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A typical ITC experiment monitors heat released or absorbed with successive injections 
of the ligand molecule. Thus, the heat change (ΔH) is directly proportional to the amount 
of binding of ligand to the macromolecule (in this case Ca++ and DREAM respectively). 
As the binding reaches saturation no heat is released or absorbed and hence, the heat 
observed post-saturation is only heat of dilution of ligand molecule. Thus, the isotherm of 
Ca++- apo-DREAM titration (fig.2-6), exhibits stoichiometric binding of two calcium ions 
(Kd = ~ 1- 10 uM) followed by one or more ions binding with much lower affinity. The 
multi-phasic isotherm may be explained, apart from the presence of multiple binding sites 
in DREAM, by the fact that metal binding to DREAM protein is accompanied by protein 
conformational changes. Specifically, previous studies from the lab have shown that apo-
DREAM exists as a tetramer and calcium-bound DREAM as a dimer [130]. Thus, the 
isotherm is too complex for quantitative derivation of thermodynamic parameters of 
individual calcium binding sites. In order to dissect the metal binding properties of the 
individual EF hands, mutant DREAM-C constructs were prepared such that the acidic 
residues at the 12th position of the calcium coordinating loop (fig 2-3) are replaced with a 
neutral residue (EF2: D150N, EF3:E186Q, EF4: E234Q). Replacing the negatively 
charged residues at the 12th position in the calcium coordination loop with a neutral 
residue considerably lowers affinity towards calcium [159, 174]. 
An overlay of the Ca++-binding isotherms for each of the EF-hand mutants in the absence 
and presence of magnesium is shown in fig-2-7A and B respectively. In the absence of 
magnesium, the isotherm of D150N (EF-2 mutated) exhibits stoichiometric binding of 
two Ca++ ions to the apo-protein but lacks the low affinity endothermic phase seen in wild 
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type, suggesting that EF-2 is the low affinity site, which shows non-stoichiometric 
binding in the wild-type isotherm. Thus, while EF-1 of  
 
 

























Figure 2-7: Comparison of Ca  binding isotherms for DREAM-C and EF-hand mutants++  (D150N, 
E186Q, and E234Q). Ca++ binding isotherms of apoDREAM-C (without MgCl2) and 
Mg++-saturated protein (5 mM MgCl2) are depicted in A and B, respectively. Wild-type 
DREAM-C, D150N, E186Q, and E234Q are shown in black, red, green, and blue, 
respectively. Figure and legend reproduced from [123]. 
DREAM protein is unable to bind Ca++ due to unfavorable substitutions in metal 
coordinating loop (fig.2-3, 2-4), EF-2 is concluded to be a low affinity Ca++ site for two 
reasons. They are- 1) DREAM binds two Ca++ ions, in equilibrium binding experiments, 
in the presence of physiological levels of Mg++ (fig.2-4), as disabling a bidentate 
coordination at loop position 12 in EF-2 primary sequence (Asp150 in DREAM as 
opposed to Glu in canonical EF hand sequence, fig.1-8) increases selectivity of this EF 
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hand to Mg++ rather than Ca++. 2) Substitution of acidic Asp side chain at loop position 
12 in EF-2 with Asn completely abolishes low affinity binding of Ca++ to apo-D150N 
mutant as compared with wild type in ITC experiments (fig.2-7A).  
The Ca++-binding isotherms of apo-E186Q (EF-3 mutated) and apo-E234Q (EF-4 
mutated) exhibit two phases that correspond to a stoichiometric binding of a single Ca++ 
ion followed by low affinity binding to EF-2 (see above). The high affinity site of EF-3 
mutant is strongly endothermic (Kd 1 µM and H = +5.2 kcal/mol) assigned to EF-4 
binding Ca++, while that of EF-4 mutant is exothermic  (Kd 1 µM and H = -2.4 
kcal/mol) assigned to EF-3 binding to Ca++. Stoichiometric calcium binding to all the 
mutants and the resemblance of mutant isotherms with different phases in wild type 
isotherm indicates that binding to each site is independent of the others and that binding 
occurs in a sequential manner. The initial phase of wild type binding isotherm (0-1 
equivalents) resembles that of E234Q and the later phase from 1-2 equivalents, resembles 
that of E186Q followed by non-stoichiometric binding in both the mutants similar to wild 
type. In addition, the binding isotherm of D150N from 0-2 equivalents closely resembles 
that of wild type, save for the initial endothermic phase which suggests a possible 
structural interaction between EF-2 and EF-3 that is abolished in D150N mutant. The 
lack of cooperative binding of calcium to the apo-DREAM-C indicates an unstructured 
protein devoid of long-range contacts that are required to stabilize the tertiary structure. 
The NMR studies described in Osawa et al. (2005)[123] indeed show poor chemical shift 
dispersion that is a hallmark of an unstructured protein (fig.2-9A). Thus, stoichiometric 
Ca++ binding to DREAM occurs in an orderly fashion first to EF-3 followed by EF-4. 
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Exothermic Ca++ binding to EF-3 and a ‘U’ shaped isotherm suggests a possibility of 
coupled equilibrium reactions that involve metal binding and concomitant protein 
conformational changes. In ITC experiments, the measured ΔH is a combination of ΔH of 
Ca++ binding that primarily involves dehydration of the ion and the ΔH of metal-induced 
conformational changes in DREAM protein. While dehydration of metal ion is an 
entropy driven process (increased randomness of solvent molecules after dehydration), 
protein conformational changes involve change in enthalpy (since a conformational 
change involves changes in hydrogen bonds, vanderwaal’s interactions) [175]. Thus, 
since enthalpy changes of Ca++, binding to EF-3 (E234Q in fig.2-7A) is exothermic 
(ΔH<0); a protein conformational change upon metal binding is indicated. Likewise, 
endothermic (ΔH>0) Ca++ binding to apo-E186Q (fig.2-7A) suggests that metal binding 
to EF-4 is entropy driven. Indeed, NMR studies on calcium bound DREAM show drastic 
conformational changes when compared with the apo-DREAM in the absence of metal 
ions and Ca++-free DREAM, in the presence of Mg++ (see below fig.2-9A and B). 
Thus, the wild-type DREAM-C has a low affinity (EF-2) and two high affinity calcium 
sites (EF-3 &4). Craig et al. (2002) showed that DREAM binds four calcium ions in their 
studies on DREAM protein using mass spectrometric methods suggesting that EF-1 
might bind calcium as well [173]. However, the primary sequence of the first EF hand 
contains unfavorable substitutions (e.g. Cys-104, Pro-105, and Thr-113) that disable 
metal binding to EF-1 as shown in other NCS proteins [126, 128] (also see section 2.1). 
Consistent with these observations, our studies also do not observe calcium binding to 
EF-1 or the enthalpy of binding is zero. The apparent discrepancy in the mass 
spectrometry study may be due to enhanced affinity of DREAM towards calcium in the 
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gas phase species. Hence, under physiological conditions EF-1 does not bind Ca++ as 
indicated by previous equilibrium binding studies (fig.2-4) as well as ITC measurements 
in the present study (fig.2-7A) 
2.3.2 Constitutive Mg++ binding at EF-2 
The primary sequence of the EF-hand loop in EF-2 contains an Asp at the 12-position, 
instead of the well-conserved Glu, which increases its selectivity to magnesium [176]. 
When ITC experiments were performed by titrating Ca++ into the protein samples in the 
presence of physiological levels of Mg++ (fig.2-7B), the isotherms obtained differed 
remarkably from those in the absence of Mg++ (fig.2-7A). The isotherm of EF-2 mutant 
strongly resembles that of the wild type with a binding stoichiometry of two, as opposed 
to at least three Ca++ in the absence of Mg++. The EF-3 and 4 mutants show one high 
affinity site each in the presence of magnesium, meaning that in the presence of 
magnesium DREAM-C can bind only two calcium ions with high affinity, to EF-3 and 
EF-4. Furthermore, the low affinity calcium binding observed in the wild type and EF-3 
and 4 mutant isotherms, in the absence of magnesium is completely abolished in all 
mutants, in the presence of magnesium.  
Taken together these observations imply that EF-2 constitutively binds Mg++ in the 
physiological conditions (with 5mM Mg++ and 0.1-100 μM Ca++) and does not bind 
calcium in the presence of Mg++. The shorter side chain of aspartate at the 12th position in 
the metal coordinating loop favors magnesium binding rather than calcium binding as 
observed in other EF-hand proteins [129] (see section 2.1). However, it must be noted 
that the presence of Asp at loop position 5 will also lead to selective binding of Mg++ to 
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EF hand suggesting other residues in the EF hand loop also govern ion-selectivity [177]. 
Constitutive Mg++ binding to DREAM stabilizes the protein structure, as seen from NMR 
studies of James Ames and Masanori Osawa (fig.2-9) and might be important in its 
interaction with DNA targets. 
The wild type calcium-binding isotherm obtained in the presence of Mg++ does not 
represent a linear combination of the mutant isotherms (Fig 2-7B). Thus, calcium binding 
to EF-3 and 4 does not represent two independent sites, suggesting some kind of 
cooperativity between the two sites because of Mg++ binding to DREAM. Magnesium 
binding confers stability to the protein structure, as seen in the NMR studies of Osawa et 
al [123], which might promote structural interaction between EF-3 and 4 as seen in the 
crystal structures of other EF hand proteins [126, 128, 135]. The recent crystal structure 
of KChIP1, a related NCS protein [128] shows calcium bound to only EF-3 and 4. The 
extensive contacts between the EF-3 and 4 may act as a switch that controls calcium-
sensitive DNA binding of DREAM, as suggested previously [74, 130].  
2.3.3 DREAM-C has a high affinity Mg++ site 
The difference in the calcium-binding isotherms in the absence and presence of Mg++ at 
physiological levels motivated us to study the magnesium binding properties of DREAM 
protein. Hence, we tested magnesium binding to DREAM-C using ITC (fig-2-8). Not 
surprisingly, the isotherm when fitted by a two-site model showed an exothermic binding 
to a single Mg++ and an endothermic binding that represents two or more Mg++. The 
exothermic phase from 0-1 equivalents of the isotherm represents binding of a single 
Mg++ followed by non-stoichiometric  endothermic binding of Mg++ (i.e. 1 or more Mg++ 
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with Kd > protein concentration used for ITC). Analysis of the binding isotherm using a 
"two site" model (Microcal Origin software) revealed that DREAM-C has one Mg++ site 
with relatively high affinity (dissociation constant of 13 µM and H = -0.79 kcal/mol), 
and two or more sites with much lower affinity (Kd in the millimolar range and H = 
+3.97 kcal/mol). 
 
Figure 2-8: Isothermal titration microcalorimetric analysis of Mg  binding to DREAM-C++ : Trace of the 
calorimetric titration of 29 x 10-µl aliquots of 2.0 mM MgCl2 into the cell containing 69 µM apoDREAM-
C (A) and integrated binding isotherm (B). The binding isotherm in B was fit using a two-site model where 
n1 = 0.91 ± 0.01, K1 = (7.5 ± 0.7) x 104 [M-1], H1 = -791 ± 90 [cal·mol-1]; n2 = 2 (fixed), K2 = (4.3 ± 0.2) x 
103 [M-1], H2 = (3.97 ± 0.06) x 103 [cal·mol-1]. Figure and legend reproduced from [123]. 
2.3.3 Calcium- and magnesium-induced conformational changes 
EF hand proteins well characterized so far for their Mg++ binding properties, calmodulin 
and parvalbumin, exhibit endothermic binding to Mg++ [175, 178]. Exothermic binding of 
Mg++ to DREAM suggests structural changes induced upon binding to magnesium. 
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Calcium-integrin binding protein (CIB), an EF hand protein family member, also exhibits 
significantly low  H that was explained by enthalpic cancellation between metal binding 
and concomitant structural changes in the protein [177]. To monitor protein 
conformational changes in a more direct manner, NMR studies on DREAM protein 
(performed by Masanori Osawa) show that both magnesium and calcium binding to 
DREAM lead to dramatic changes in the NMR spectra (Fig. 2-9).   The NMR spectrum 
of apo protein exhibits broad resonances with very narrow chemical shift dispersion, 
indicating an unstructured molten-globule state.  By contrast, the spectra of both Mg++-
bound and Ca++-bound states exhibit sharper peaks with much greater chemical shift 
dispersion, consistent with the formation of stable tertiary structure. (turn overleaf for 
fig.2-9). 
Size-exclusion chromatography studies and dynamic light scattering analysis both 
indicate that DREAM and all the EF-hand mutants are monomeric in solution in the 
presence of Mg++ (and absence of Ca++), whereas Ca++-bound DREAM forms a stable 
dimer (Fig. 2-10).  A similar Ca++-induced dimerization has been reported previously for 
other recoverin-like proteins such as neurocalcin [127] and KChIP1 [128].  The calcium-
induced dimerization of DREAM is consistent with the recent crystal structure of Ca++-












Figure 2-9:  Two-dimensional 15N-1H HSQC NMR spectra of DREAM. NMR spectra of apo-DREAM-C 
(A), Mg++-bound DREAM-C (B), and Ca++-bound (C) DREAM-C. Each protein sample was uniformly 
labeled with nitrogen 15, and spectra were recorded at 600-MHz 1H frequency. Figure and legend 




Figure 2-10: Molecular weight estimation of DREAM-C by size exclusion chromatography (SEC). A, size 
exclusion chromatograms of Mg++-(solid line) and Mg++/Ca++-DREAM-C (dotted line). 100 µl of 200 µM 
protein solution were applied onto Superdex 200 HR (10/30) column (Amersham Biosciences) pre-
equilibrated with the buffers containing 10 mM Hepes·NaOH (pH 7.6), 150 mM NaCl, 5 mM MgCl2, 1 
mM dithiothreitol, and 1 mM EGTA or 5 mM CaCl2 for Mg++-DREAM-C and Ca++-DREAM-C, 
respectively. B, the standard curve for the molecular mass determination was created using -amylase (200 
kDa), alcohol dehydrogenase (150 kDa), transferrin (81 kDa), carbonic anhydrase (29 kDa), and myoglobin 
(17 kDa). Void volume of the column (Vo) was obtained as 7.81 ml using blue dextran (2000 kDa), and Ve 
is a volume of elution of each sample. Arrows indicate Ve/Vo values for Mg++- or Ca++-bound DREAM-C 
(50 µM). The molecular mass based on amino acid sequence of DREAM-C is 25 kDa. Estimated mass of 
Mg++-DREAM-C : 30 kda (slightly higher apparent mass may be due to shape effects of the protein); Mg++- 
Ca++-DREAM-C: 50 kda. Metal binding to His-tag was previously shown to be negligible [170]; proteins 
were expressed in bacteria exactly as mentioned in the methods section above. Figure and parts of legend 
sourced from [123]. 
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2.3.4 DNA Binding by EF-hand mutants 
Electrophoretic mobility shift assay on the single EF-hand mutant proteins (Fig.2-11), by 
Kit Tong and Alexandra Dace, shows that all the mutants bind to DNA under the 
conditions previously described for wild type DREAM [74, 130].  The EMSA bands for 
each of the mutants disappear upon the addition of saturating Ca++, suggesting the Ca++-
bound forms of mutants (similar to wild type) do not bind to DNA.  These results suggest 





Figure 2-11. Fluorescence Electrophoretic mobility shift assay of DREAM-C/DRE interaction. 5 nM Cy5 
labeled DRE oligonucleotide in 10 mM HEPES, pH 7.9, 2 mM dithiothreitol, and 8 mM Mg++ was 
incubated with 0–70 µM wild-type (A), D150N (B), E186Q (C), and E234Q (D) DREAM-C proteins 
expressed in bacteria exactly as mentioned in the methods section above, in the presence and absence of 10 





2.3.5 Mechanism of Ca++-sensitive DNA binding 
The metal binding studies described above combined with previous studies on DREAM 
function can be summarized in the form of a model as shown in Fig.2-12. Magnesium 
bound DREAM in solution is a monomer, which binds to DNA as a tetramer at resting 
calcium levels and represses transcription  [74, 130]. A rise in nuclear calcium 
concentration causes Ca++-induced conformational changes in DREAM that promote 
dissociation of the tetramer into Ca++-bound dimers that then dissociate from DNA and 
lead to derepression of transcription.  The next chapters in this thesis attempt to identify 

































DREAM protein acts as a transcriptional repressor by physically interacting with a stretch 
of DNA, referred to as the Downstream Regulatory Element (DRE), that is present 
downstream of the transcription start site in the prodynorphin gene ([74], fig.3-1). 
DREAM provides a converging point between calcium and cAMP-mediated regulation of 
prodynorphin gene expression [74, 114]. Calcium binding to DREAM leads to its 
dissociation from DNA and hence derepression. DREAM affects gene expression 
through its interactions with α-CREM  [142] and CREB [131] proteins that are modulated 
by cAMP-induced activation of protein kinase-A. While phosphorylation of α-CREM by 
protein kinase A (PK-A) is not essential for DREAM- α-CREM interaction, 
phosphorylated α-CREM interacts more strongly with DREAM and dissociates it from its 
DNA targets leading to derepression [142]. DREAM binds to CREB and impairs its 
ability to recruit CBP, in the absence of calcium, thus inhibiting CRE-dependent (cAMP 
response element) transcription [131]. More recently, DREAM is also reported to interact 
with C-terminal binding proteins [124] and repress transcription. Interestingly, DREAM 
also acts as transcriptional activator when it interacts with vitamin-D receptor [125]. Thus 
elucidating the mode of DNA recognition of DREAM protein would certainly help in 
understanding its effect on gene expression in relation to its DNA and multiple protein 
targets inside the nucleus.  
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Zaidi et al. (2004) showed that DREAM could translocate into nucleus under elevated 
calcium levels [141]. However, calcium binding to DREAM is not a prerequisite for its 
nuclear translocation as a mutant disabled for calcium binding also translocated to the 
nucleus [141]. In a study carried out to identify the key bases involved in binding to 
protein the sequence “GTCA” was reported to be important in specific DNA recognition 
by DREAM protein. Furthermore the nucleotide ‘G’ is the single most important 
determinant of the specificity [179]. Gel retardation experiments with mutated DRE 
wherein the ‘G’ is replaced with an ‘A’ show impaired DNA recognition by DREAM 















 Dynorphin DRE:  









Figure 3-1 Electrophoretic mobility shift assay (EMSA) of DREAM devoid of the N-terminus in the 
presence and absence of calcium (left panel). The right panel shows the EMSA reactions where the labeled 
probe is competed with cold DRE, mutated DRE’s (shown in the bottom panel, underlined residues 
mutated as described) and non-specific c-AP-1 DNA   (Figure adapted from [130]) 
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DREAM is believed to bind DNA as a tetramer, based on evidence from light-scattering 
studies performed on DREAM protein in solution with dynorphin and c-fos DRE 
elements[130]. These studies showed that the hydrodynamic radius of predominant 
species corresponds to a DREAM tetramer bound to DRE in a 1:1 stoichiometry. Other 
examples of proteins binding to DNA as tetramer include Arc repressor of phage P22 
[180], p53 [181] and diphtheria toxin repressor [182].  The p53- DNA interaction 
comprises of two individual p53 dimers interacting with respective half-sites on DNA 
[181]. However, in the case of diphtheria toxin repressor two sets of homodimers contact 
DNA from both the sides and interact with two major grooves each on a 24 base DNA 
sequence [182]. Previous DNA binding studies on DREAM showed calcium sensitive 
binding to DNA [74, 130] at an approximate Kd = 30μM [130]. Lack of high-resolution 
structure of DREAM protein complexed with DNA impedes knowledge of its DNA 
recognition motif. Since the primary sequence of DREAM protein does not contain any 
known consensus DNA binding region, I proposed to identify the residues in  DREAM 
protein responsible for DNA recognition using yeast-one hybrid method, a variant of 
yeast two hybrid [183]. Other methods to study protein-DNA interactions include gel-
retardation assays, chromatin immunoprecipitation and DNA foot-printing using enzymes 
(DNAaseI, Exonuclease III) or chemical agents (hydroxyl radicals) [184-186]. More 
recently, mass spectroscopy was also described to be a robust way to characterize 
protein-DNA interaction [187-189]. However, the one–hybrid method is an efficient in 
vivo method and a high-throughput way of screening multiple single-site mutants of 
DREAM protein that are defective in DNA binding, hence identifying the specific 
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residues responsible for DNA recognition. The schematic illustration of the method is 







Figure 3-2: Matchmaker One-hybrid system for detecting DREAM-DRE interaction. Figure courtesy: 
James Ames. 
 
3.2 Yeast one-hybrid 
An interesting variant of the two-hybrid system [183], the yeast one-hybrid involves the 
fusion of a transcriptional activation domain to a putative DNA binding protein plus the 
target DNA binding element inserted upstream of a reporter gene. A positive protein-
DNA interaction would result in activation of reporter gene transcription. The one-hybrid 
method can be used to identify unknown proteins that might bind to a known DNA 
element, unknown promoter elements to which a known protein with DNA binding 
activity could interact, and the residues in the protein that are responsible for protein-
DNA interaction  [190-192]. One-hybrid screens have been used to identify proteins that 
bind a TGFβ control DNA element [193], and to identify DNA binding residues in 
bovine papilloma virus E1 protein [194].  
In order to embark upon screening single site mutants of DREAM protein, it must be 
established that DREAM-DNA interaction would prove to be a viable model to screen 
using the one-hybrid method. Hence I set out to perform the control experiment to test for 
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DREAM-DNA interaction using wild type DREAM protein fused with Gal4 or B42 
activation domains and the DRE elements (either three tandem repeats or a single DRE 
site) inserted upstream of either the β-galactosidase gene or HIS3 reporter gene. If 
DREAM protein fused to the GAL4 activation domain interacts with the DRE element 
fused upstream of a reporter gene, the activation domain would drive the expression of 
the reporter gene, which can be observed when yeast strains containing the protein fusion 
and the reporter constructs are grown on selective media.   
3.3 Materials and Methods 
3.3.1 Yeast strains used in this study 
YM4271 (Genotype: MATa, ura3-52, his3-200, ade2-101, ade5, lys2-801, leu2-3, 
112,trp1-901, tyr1-501, gal4D, gal8D, ade5::hisG) Transformation Markers: trp1, leu2, 
ura3, his3) EGY48 (Genotype: MATa, his3, trp1, ura3, LexAop(x6)-LEU2, Transformation 
Markers: his3, trp1, ura3).  
3.3.2 Plasmid constructs used in this study 
The vectors used in the one hybrid study, pJG4-5 (invitrogen), pLacZi (Clontech) and 
plasmids with protein fusion in pJG4-5 and reporter constructs for positive control were 
kindly provided by Dr. Harold Smith. Plasmid maps are shown in the fig 3-3. Plasmid 
constructs used in this study are shown in Fig. 3-3. DREAM ORF sequence amplified by 
PCR using oligos ( forward primer: 5’-AAA AGA ATT CAT GCA GAG GAC CAA 
GGA AG-3’, reverse primer: 5’-AAA AGT CGA CCT CGA GTT ACT AGA TGA 
CGT TCT C-3’) and pet15b-DREAM (obtained from M. Ikura) as template. After 
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digestion with EcoRI and SalI, the PCR products were fused in frame with the B42 
activation domain in the pJG4-5  
 A.   B.         
 
C. D .  
 
Figure 3-3: Plasmid maps of vectors used in the one-hybrid study (A,C,D:[195]; B:[196]),  
 
vector at EcoRI and XhoI sites and Gal4 activation domain in pGAD-424 at EcoRI and 
SalI sites. DRE oligos (Lac-DRE) with three tandem repeats of DRE site (sense: 5’-AAT 
TCA TCG ATG CCG GAG TCA AGG CCG GAG TCA AGG CCG GAG TCA 
AGG-3’ Antisense: 5’-TCG ACC TTG ACT CCG GCC TTG ACT CCG GCC TTG 
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ACT CCG GCA TCG ATG-3’) and single DRE site (sense: 5’-AAT TCA TCG ATG 
CCG GAG TCA AGG-3’antisense: 5’-TCG ACC TTG ACT CCG GCA TCG ATG-
3’) were first annealed were annealed by heating to 95 o C and slowly cooling to room 
temperature. The annealed oligos were cloned into pLacZi at EcoRI and SalI sites. His-
DRE oligos (sense:  5’-AAT TCG TCG ACG CCG GAG TC A AGG CCG GAG  
TCA AGG CCG G AG TCA AGT-3’ and antisense: 5’-CTA GAC TTG ACT CCG 
GCC TTG ACT CCG GCC TTG ACT CCG GCG TCG ACG-3’) were annealed 
similar to the Lac-DRE oligos. The annealed oligos were cloned into pHisi-1 vector 
digested with EcoRI and XbaI enzymes. All bacterial transformants were selected on 
Luria-bertani media supplemented with 100 μg of ampicillin.
3.3.3 Yeast transformation 
Transformation of yeast strains was performed as described by the manufacturer 
recommended protocol ([197], small-scale yeast transformation). Colonies from freshly 
streaked YPAD (see section 3.3.4) plates were inoculated in 10 ml cultures and grown 
overnight at 30o C (~OD600 > 1.5). Cultures were then diluted into 50ml or 100 ml of 
fresh media until the OD600 = 0.2-0.3 and grown for additional 2-3 hours at 30o C, until 
OD600 = 0.4-0.6. The cells were then harvested by spinning the cultures at 1000 x g for 5 
min at room temperature followed by washes with sterile distilled water and 1x TE buffer 
(0.01 M Tris-HCl, 1 mM EDTA, pH 7.5 sterile). The final cell pellet is resuspended in 
0.5 ml of sterile and freshly prepared 1x Lithium acetate (0.1 M Lithium acetate (LiOAc), 
sterile). 0.1 ml of the cell suspension was used for a single yeast transformation reaction. 
0.1 ml of the yeast cell suspension was added to 0.1 μg (1 μg in the case of reporter 
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plasmid as it involves genomic integration) of plasmid DNA and 100 μg of sonicated 
salmon sperm DNA (used as carrier DNA). After mixing thoroughly using a pipette, 0.6 
ml of PEG/TE/LiOAc solution (40% polyethylene glycol (PEG), 0.01 M Tris-HCl, 1 mM 
EDTA, pH 7.5, and 0.1M lithium acetate) was added to the mixture and mixed using the 
vortexer. This reaction mixture was then incubated by shaking at 230 rpm on a shaker at 
30o C for 30 minutes. After addition of 70μl of DMSO, the transformation reaction was 
subjected to heat shock at 42 o C for 15 min. The cells were then placed on ice for 2 min 
and spun at 14,000 rpm for 5 seconds. The supernatant was decanted and the cells 
resuspended in 0.5 ml 1x TE. 100 μl of the suspension was then plated on selective media 
to screen for transformants and incubated at 30o C for 2-4 days.  
Yeast transformations were carried out sequentially, first with the reporter plasmid 
(corresponding to pLacZi or pHisi-1 vectors) followed by the protein expression plasmid 
(corresponding to pGAD-424 or pJG4-5 vectors). The reporter plasmids were linearized 
by restriction digestion (NcoI digestion of pLacZi and XhoI digestion of pHisi-1 reporter 
vectors) before using for transformation. Yeast strains transformed with pLacZi reporter 
vectors were selected in synthetic dropout media devoid of uracil, and transformants 
containing pGAD424 and pJG4-5 plasmids were selected in media devoid of leucine and 
tryptophan respectively. Double transformants were selected using media devoid of uracil 
and tryptophan. The double transformants thus obtained were patched onto the selective 
media to observe the reporter gene expression.  
 59 
3.3.4 Yeast media preparation 
Synthetic dropout media were prepared to select transformants containing the respective 
plasmid constructs harboring the selective marker as described in the Clontech yeast 
protocols handbook [197]. YPAD contains 20 g/L Difco peptone, 10 g/L Yeast extract, 
20 g/L glucose and 20 g/L Agar (for plates only) supplemented with 20mg/L of adenine. 
Synthetic dropout media were prepared with a base of 5 g/L of ammonium sulfate, 1.7 
g/L of yeast nitrogen base (without amino acids and ammonium sulfate), 2% glucose, 2% 
Agar (for plates only) combined with a 0.6 g/L of SD/ DropOut powder commercially 
obtained from clontech (–His/–Leu/–Trp/–Ura DO Supplement Cat # 630425). Except for 
the selective marker required for transformed plasmids (pLacZi: uracil, pHisi-1: histidine, 
pGAD424: leucine, pJG4-5: tryptophan) the other missing components were added to the 
media in tiny amounts in approximation. Where mentioned, when His reporter strains are 
screened, the selective media also contained 15mM, 30mM, 45mM, or 60 mM 3-amino 
triazole which inhibits leaky expression of the His3-reporter gene. X-Gal indicator plates 
contained 2.8 mM KH2PO4, 4.2 mM K2HPO4.3H2O and 2% galactose plus 1% raffinose 
instead of glucose. pJG4-5 has a galactose-inducible promoter that only expresses the 
fusion protein in the presence of galactose as a carbon source and is inhibited by glucose. 
For screening healthy strains from stocks contaminated with ‘petite’ mutants [198] the 
stocks were streaked onto media with ethanol and glycerol as carbon source (YPEG 
media 20 g/L Difco peptone, 10 g/L yeast extract, 3% v/v glycerol 2% v/v ethanol and 20 
g/L Agar supplemented with a speck of adenine). 
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3.3.5 Colony lift filter assay 
Double transformants containing the lacZ reporter vectors and protein expression vectors 
were patched onto a fresh double dropout plate. These plates were then incubated at 30o 
C for 2-4 days.  A sterile Whatman #5 filter paper was pre-soaked in 5 ml of Z buffer/ X-
gal solution [16.1 g/L Na2HPO4. 7H2O, 5.5 g/L NaH2PO4. H2O, 0.75 g/L KCl, 0.246 g/L 
MgSO4. 7H2O, pH 7.0, + 1.67 ml of 20mg/ ml stock solution of X-gal (5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside) dissolved in N,N-dimethylformamide (DMF)] 
in a clean petri plate. Colonies were lifted using a clean and dry filter paper, the 
orientation marked and the filter immediately immersed in liquid nitrogen colony side up 
for 10 sec. The filter was then thawed and placed on the presoaked filter in Z-buffer/X-
gal solution colony side up, incubated at 30o C, and observed every 5 min to check for 
blue coloration.  
3.3.6 Test for protein-DNA interaction in the yeast 
DNA binding was screened using blue-white colony screening on double dropout media 
containing X-gal, galactose, and raffinose as carbon source (SD/-ura/-trp/X-gal: SD 
media + 10 ml of 10X KPO4 stock buffer (3.8 g KH2PO4, 9.58 g K2HPO4.3H2O in 100 
ml distilled H2O) + 10 ml of 10X galactose/raffinose solution (20 g galactose, 10 g 
Raffinose in 100 ml distilled H2O), as pJG4-5 vector has an inducible promoter that 
activates protein expression in the presence of galactose as carbon source. 
 61 
3.4 Results 
3.4.1 DRE reporter yeast strains exhibit high background expression under 
different reporter systems
Three tandem repeats of DRE element, (5’-GCC GGA GTC AAG G -3’) 3, were 
inserted upstream of β-galactosidase in pLacZi plasmid (see section 3.3). When this 
reporter plasmid was co-transformed into yeast (YM4271 strain) along with pGAD-
DREAM plasmid that contains DREAM protein fused to Gal4 activation domain, a 
successful interaction between DREAM and DRE would lead to activation of the reporter 
gene by the Gal4 activation domain. Thus, the assay helps monitor the reporter gene 
expression by using X-gal as substrate for β-galactosidase (LacZ) reporter gene 
expression. β-galactosidase is an enzyme that is a product of LacZ gene in the lac operon, 
which can hydrolyse the colorless X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) 
substrate to give a blue coloration to the colony [1].  
Initial experiments were carried out, with reporter plasmids containing three tandem 
copies of the DRE element, to increase the probability of DREAM-DRE interaction. A 
yeast reporter strain transformed with the reporter vector devoid of DRE was used as a 
negative control. The yeast strain that contains p53Blue and pGAD53m plasmids, 
harboring a p53-specific DNA element in pLacZi vector and p53 protein in pGAD424 
vector respectively, was used as positive control. The colony lift filter assay was 
performed to detect expression of the lacZ reported gene (Fig.3-5). The positive control 
reporter strain exhibited blue coloration after ~30 min from the incubation start time (spot 
8 in fig. 3-4). After ~ 70 min, all the three strains harboring the DRE in their reporter 
plasmids exhibited blue coloration (spots 1, 2, 3 in fig.3-4).  In contrast, none of the 
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strains containing the empty reporter vector, pLacZi (spots 4, 5, 6 in fig.3-4), exhibited 
blue color even after two hours of incubation at 30o C. Thus, the Downstream Regulatory 
Element (DRE) is activating lacZ reporter gene expression spuriously and hence cannot 
be used to assay DREAM binding activity.   
 
 
Figure 3-4: Colony lift filter assay of yeast double transformed reporter strains (host: YM4271). 1,2,3 show 
the pLac-DRE reporter strains transformed with pGAD-424, pGAD-DREAM and pGAD-53m protein 
plasmids respectively. 4,5,6 show pLacZi reporter strains and 7,8,9 show p53Blue reporter strains 
transformed with each of the three protein plasmids respectively.  The picture was taken between ~70-75 
min after the start of incubation at 30oC, the dark spots indicate blue coloration of the yeast patches and 
positive reporter activity. 
To overcome this problem, a His3 reporter gene was tested because background 
expression can be controlled by 3-amino triazole (3-AT). 3-AT is a histidine analogue 
that inhibits histidine biosynthesis by inhibiting the HIS3-encoded enzyme imidazole 
glycerol phosphate dehydratase, which is required in yeast for the synthesis of the amino 
acid histidine [199] [200]. In order to identify the concentration of 3-AT that sufficiently 
inhibits background growth on histidine-deficient media, each of the His3 reporter yeast 
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strains were grown in the presence of 15 mM, 30 mM, 45 mM, or 60 mM 3-AT on SD/-
His medium. However, contrary to the expectation that 3-AT would inhibit background 
HIS3 expression leading to growth arrest, the reporter strains containing the DRE 
element showed robust growth even at 60mM 3-AT (Table 3-1). While the reporter strain 
with pHisi-1 alone ceased to grow at 60 mM 3-AT, the strains harboring the DRE 
element did not show growth arrest even at 60 mM 3-AT. The strains with p53-specific 
DNA element showed reduced growth at 60mM 3-AT. 
3- AT 
concentration pHisi-1 pHis-DRE p53His 
15 mM 3-AT ++++ ++++ ++++ 
30mM 3-AT +++ ++++ ++++ 
45 mM 3-AT + ++++ ++ 
60mM 3-AT - ++++ + 
 
Table.3-1: Qualitative results in terms of cell viability in the presence of 3-AT, of the yeast reporter strains 
harboring His reporter plasmids (host: YM4271). 
These results were attributed either due to overactive reporter due to the presence of three 
tandem copies of DRE element or leaky reporter gene expression from the results in the 
case of empty reporter vector. Hence, all the reporter plasmids were reconstructed with a 
single copy of DRE upstream of the reporter gene and used to test the protein-DNA 
interaction. At this stage, it became very difficult to work with the yeast strains as 
repeated transformations to obtain double transformants produced no colonies on the 
double dropout plates. This problem was possibly due to a mutation in the host strain that 
leads to a mitochondrial defect and slows down the growth rate dramatically. These 
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mutants are referred as “petites” [198]. Repeated attempts to rescue the strains by 
selecting for healthy strains on minimal media using glycerol and ethanol as carbon 
sources were unfruitful and eventually, the yeast strains we had even ceased to grow on 
rich media (YPAD). Hence, a different yeast strain, EGY48, was used in subsequent 
experiments. 
3.4.2 DREAM cannot bind DNA in the one-hybrid:  
In order to check the suitability of the yeast-one hybrid to test DREAM-DNA interaction, 
experiments were carried out using a different strain of yeast, EGY48. The experimental 
design was similar to previous set of experiments described in section 3.4.1. When the 
reporter yeast strain containing the DRE element (either single copy or three tandem 
repeats) inserted upstream of the lacZ reporter gene, was transformed with vector 
containing DREAM protein, and grown on selective media containing X-gal and 
galactose (to induce protein expression), there was no reporter gene expression, as 
observed by the lack of blue coloration (fig.3-5). The positive control containing the 
reporter and protein plasmids obtained from Harold Smith lab, showed blue coloration as 
expected (fig. 3-5). The absence of reasonable reporter gene expression in case of 
DREAM-DRE containing double transformant yeast strains points to a lack of or 
impaired interaction between DREAM and DRE. Effectively, this means that under the 
conditions of this assay system DREAM protein could not recognize the DRE element. 
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Figure 3-5:  DREAM does not bind DNA in one hybrid. Right panel shows the experimental design where 
the columns correspond to the protein vector (PV) and rows correspond to reporter vectors (RV). Each 
successive three patches on the plate represent the three protein plasmids transformed into the designated 
reporter vector in triplicates (denoted by underlined colors; green: pLacZi; orange: pLacZi with three 
tandem copies of DRE fused upstream of reporter (lacZ); red: pLacZi with single copy of DRE fused 
upstream of reporter; blue: pLacZi with positive control reporter (HESr) fused upstream of reporter). 
Results are denotedby + for blue coloration indicative of reporter gene expression, - for no reporter 
expression. E/O indicates expected/observed results. 
3.5 Discussion 
Two different yeast strains, YM4271 and EGY48, used to test DREAM-DRE interaction 
showed different results in the yeast one-hybrid experiments. The difference in results 
can be explained due to differences in each of the yeast strains and the different methods 
used to probe DREAM-DRE interaction (colony-lift assay vs. blue-white colony 
screening respectively).While the experiments using YM4271 yeast strain resulted in 
spurious activation of reporter gene expression, experiments with EGY48 resulted in no 
activation of reporter gene expression. The spurious activation in strain YM4271 
precludes any further analysis. However, there are a number of possible reasons for the 
apparent lack of DREAM-DNA interaction when using yeast strain EGY48. They are 1) 
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high resting calcium levels in yeast that might hamper its DNA recognition; 2) 
sequestration/inhibition by endogenous yeast factor; 3) insufficient DREAM protein 
expression; 4) possible degradation of DREAM protein; 5) disruption of DNA binding 
site due to fusion with B42 activation domain; and 6) mis-localization of DREAM 
protein, all of which can be tested experimentally. 
While resting nuclear calcium levels in Sacharomyces cerevesiae are yet unknown, 
resting cytosolic calcium levels were shown to be in the 10-9 M range [37] at which 
concentrations wild-type DREAM is unable to bind calcium [123]. A one-hybrid 
experiment with a dominant-negative DREAM mutant that has its calcium binding sites 
impaired would address the problem with abnormal calcium levels in yeast. In the event 
the absence of reporter gene expression was due to high calcium in yeast, the dominant 
negative mutant, which is incapable of binding calcium, would prevent calcium-induced 
inhibition of DREAM-DRE interaction thereby leading to reporter gene expression. 
DREAM is known to interact with various proteins that regulate transcription in 
eukaryotes ([124, 125, 131, 142]). Thus, it is quite possible that an endogenous yeast 
factor is sequestering DREAM protein from binding DNA by means of a physical 
interaction. A pull down experiment with lysates of yeast strains containing the 
expression plasmid harbouring DREAM ORF, using anti-DREAM antibody would 
address this problem. Pull-down of a yeast protein along with DREAM would imply 
sequestration of DREAM protein by an endogenous factor resulting in lack of reporter 
gene expression. Absence of a yeast protein in the pull-down experiment might indicate 
an additional possibility wherein the endogenous yeast protein directly interacts with the 
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DRE element, thus precluding DREAM binding to DRE and repressing the expression of 
the reporter gene. Similar experiments with the yeast strains used for hybrid with 
YM4271 as host strain would address if an endogenous factor were activating reporter 
gene expression either in conjunction with or independent of DREAM protein. The 
presence of blue color in all the reporter strains that contain the DRE element in the 
experiments involving YM4271 (fig.3-4) suggests a possible involvement of yeast 
endogenous factor that might be activating the reporter gene expression.  
The one-hybrid experiment involves expression of DREAM protein in yeast. Failure to 
detect a DREAM-DRE interaction might imply low protein levels resulting due to 
insufficient protein expression or due to protein degradation. Expression of recombinant 
proteins in yeast may lead to activation of stress pathways, prime among which is the 
unfolded protein response [201] that may result in ER-associated degradation (ERAD) of 
recombinant protein. If DREAM fusion protein in yeast were expressed in an unfolded 
state, the protein might be degraded and hence unavailable for binding to the DRE. A 
western blot using anti- DREAM antibody, on the yeast protein extracts prepared from 
the reporter strains with DREAM plasmid grown in the presence of galactose and 
raffinose as carbon source would test the level of expression of DREAM in the yeast cells. 
Furthermore, the occurrence of degradation may be inferred if the anti-DREAM antibody 
recognizes low molecular weight polypeptides, representing DREAM degradation 
products, on the western blot. 
Another distinct possibility that can explain the failure to detect DREAM-DRE 
interaction would be impaired nuclear translocation of DREAM in the yeast. DREAM 
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protein requires elevated levels of calcium in order to translocate into the nucleus, 
although not in a quantity where it can bind calcium itself [136]. Moreover, DREAM 
does not contain a nuclear localization signal and so might have to depend on other 
factors, as yet unknown, to translocate into the nucleus. It is plausible that such factors 
responsible for its nuclear localization in mammals are absent in yeast cell. Further, the 
protein folding resulting due to DREAM-B42AD fusion may result in masking of the 
nuclear localization signal in B42AD as well. Immunofluorescence experiments using 
anti-DREAM antibody would directly monitor the localization of DREAM protein in the 
yeast cell.  
One drawback of the yeast-hybrid system stems from the possible misfolding of the 
protein because of fusion to the activation domain [202]. Thus, improper folding of 
DREAM protein when fused with B42 activation domain could have precluded its 
interaction with DRE in yeast. Misfolded proteins are generally prone to forming 
insoluble aggregates. Separation of soluble and insoluble fractions of the yeast lysates 
that contain DREAM expression plasmid coupled with a western blot on each of the 
fractions using anti-DREAM antibody would identify if the protein forms insoluble 
aggregates. 
In summary, the yeast one–hybrid experiment carried out to test DREAM-DRE 
interaction could not detect binding as visualized by the absence of reporter gene 
expression. With multiple reasons possible for to explain this failure, experiments 
directed to probe each of these options deviate from the initial objective of mapping DNA 
binding residues in DREAM protein. Hence, an in vitro approach to probe the protein-
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DNA interaction using chimeric protein constructs was adopted as an alternative method 
to identify the DNA binding motif in DREAM protein.  
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Protein-DNA interactions play a pivotal role in the regulation of life processes such as 
DNA replication, gene expression and chromosome maintainence. In response to external 
or internal stimuli, such as growth factors and metabolic stress respectively, there occurs 
a remarkable alteration in the protein-DNA “interactome” (the complete set of protein-
DNA interactions in vogue at a given instant in space and time in the cell), thereby 
leading to changes in gene expression. A number of proteins (e.g. transcription factors 
and repressor proteins) contain specialized structural motifs such as helix-loop-helix 
[203], helix-turn-helix [204], leucine zipper and zinc finger [205] motifs in their tertiary 
structure that help in the recognition of DNA and regulate gene expression. These motifs 
recognize DNA via both direct and indirect interactions between the polar side-chains of 
amino-acid residues and the nitrogenous bases in DNA. Sequence-specific interactions 
are formed mainly by intermolecular hydrogen bonding and/or salt bridge interactions in 
the major groove [206]. Non-specific interactions with the phosphate backbone also 
contribute to the binding energy by inducing bending [207] or kinking [208] in the 
overall structure. 
DREAM protein binds to a sequence of DNA referred as the Downstream Regulatory 
Element (DRE) ([74, 130] and fig. 3-1) and represses transcription of various genes such 
as prodynorphin [74], hrk [118] and calcitonin [119]. DREAM was shown to interact 
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with DNA using in vivo reporter assays that measured chloramphenicolacetyl transferase 
(CAT) [74, 179] reporter activity in neuronal cell lines [74, 179]. Ledo et al. (2000) 
characterized this interaction using mutated DRE probes and showed that the sequence 
‘GTCA’ in DRE is the core element required for DREAM-DRE interaction. By 
generating single base mutations in this consensus sequence they report that the 
nucleotide ‘G’ is the single most important determinant that governs the protein-DNA 
recognition. Furthermore, DNA elements with an inverted GTCA core- ACTG,  can also 
interact with DREAM [179] as is the case with c-fos DRE [74].  
Much is known about the effects of DREAM-DNA interaction on gene expression [74, 
119, 125]; however, the exact region of the protein structure that recognizes DNA is still 
unknown. Since an attempt to structurally characterize DREAM-DRE interaction using 
the yeast one-hybrid system failed to yield positive results (Chapter 3), I decided to probe 
the structure of the DNA binding site using chimeric protein constructs with specific 
regions of DREAM swapped with corresponding regions of recoverin. Recoverin is an 
EF hand calcium sensor protein in retinal rod cells [209] that has ~45% sequence identity 
to DREAM. Therefore, the main chain structures of DREAM and recoverin are expected 
to be very similar such that the swapping of individual EF-hands between recoverin and 
DREAM should cause a minimal perturbation to the overall structure.  Although the main 
chain structures of recoverin and DREAM are very similar, their surface charge 
properties are clearly different.  The surface of recoverin contains many negatively 
charged side chain groups of Asp and Glu, whereas the surface of DREAM is overall 
positive. The net negative surface of recoverin may explain recoverin’s inability to bind 
negatively (-) charged DNA in the presence or absence of calcium (see section 4.3.5). In 
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addition, the calcium binding properties of recoverin vary from that of DREAM protein.  
EF hands 3 and 4 of DREAM are high affinity calcium binding sites and EF-2 is a 
magnesium binding site (see section 2.1), whereas EF-2 and EF-3 of recoverin bind 
calcium [210] and recoverin does not contain a specific magnesium-binding site (see 
section 2.1 for description). DREAM protein exhibits a calcium-induced dimerization, 
whereas recoverin does not (see section 4.3.3). Thus, generating DREAM-recoverin 
chimeras would not only alter the charge of the putative DNA binding site but also alter 
the metal binding and oligomerization properties of the protein as well.  
In this study, I prepared a variety of chimeric constructs described below (Fig. 4-1) by 
systematically substituting each individual EF-hand of recoverin into DREAM.  I report 
here my studies on these chimeric constructs designed to probe the structure of the DNA 
binding site and elucidate the calcium-dependent protein oligomerization properties. 
Previous in vitro studies on DREAM-C (C-terminal residues of DREAM, 65-256 
comprising the four EF hands) showed that the N-terminal tail (residues 1-64) is not 
essential for functional DNA binding [130]. Hence, all the DREAM-Recoverin chimeras 







Figure 4-1: Schematic representation describing the generation of DREAM-Recoverin chimeras (DRC’s). 
Affinity of EF hands to calcium or magnesium is indicated below each chimera. Black rectangles indicate 
the name of each protein, light turquoise rectangles indicate EF hands from DREAM and blue rectangles 
indicate EF hands from recoverin. (CH: C-terminal Helix). 
 
4.2 Materials and Methods  
4.2.1 Construction of DRC plasmids 
Full- length cDNA constructs coding for DRC proteins were generated using two 
successive rounds of PCR amplification termed as SOEing (Splicing by Overlap 
Extension) as described previously [211]. DREAM cDNA cloned into pet15b was 
described previously [130] and recoverin cDNA cloned into pet11a was obtained from 
Nobuko Katagiri (CARB). Chimeric DRC fragments were cloned into pet15b at NdeI and 
XhoI sites. DREAM or Recoverin cDNA fragments were amplified using PCR using Pfu 
turbo DNA polymerase (Stratagene or recombinant enzyme prepared in Zvi Kelman lab) 
and oligos described in Table 4-1. Standard PCR conditions used are 1) 95 oC for 2’, 2) 
95  oC for 1’, 3) 62 oC for 1’, 4) 72 oC for 1’ 5) linked to step 2) for 29 cycles. Following 
the final cycle an additional 10’ of extension was done at 72 oC to ensure complete 
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extension of 3’ termini. PCR products were purified either by Geneclean-II (Qbiogene) or 
by Wizard PCR purification kit (Promega) and quantified by ultra violet-
spectrophotometry. An absorption spectrum from 240-340 nm was obtained and after 
correction for baseline, an OD260 of 1.00 was equated to 50 μg/ml of double stranded 
DNA. Equimolar amounts of DREAM and Recoverin PCR fragments (0.2pmol) were 
used as templates for a second round of PCR with forward and reverse primers of N-
terminal and C-terminal halves respectively, thus generating full-length DRC DNA 
fragments. Pet15b vector DNA was sequentially digested with NdeI (New England 
biolabs) overnight followed by XhoI (NEB or Takara) digestion for 3-5 hours at 37 oC 
using compatible digestion buffers for each enzyme from NEB. The 5’ phosphates were 
cleaved by incubating the double digested vector with Shrimp alkaline phosphatase 
(Amersham lifesciences) to prevent self-ligation of the vector during ligation. The 
purified DRC full-length PCR fragments were digested with NdeI and XhoI 
simultaneously for overnight at 37 oC using compatible digestion buffer from NEB 
(NEB-4). The digested pet15b vector and PCR products were then mixed in 1:5 (30 fmol: 
150 fmol) ratio in a total volume of 5-7.5 μl and ligated at 16 oC for 1 hour after adding 
equal volume of solution I (2x ligation mix) from DNA ligation kit ver 2.1 from Takara 
Bio Inc.  10 μl of the ligation reaction was transformed into sub-cloning efficiency DH5α 
competent cells (GIBCO-BRL) and plated on LB media supplemented with 100 μg/ml of 
ampicillin and grown overnight at 37 oC. Positive clones were screened after minipreps 
using Wizard plus miniprep kit (Promega), by diagnostic double digest using NdeI and 
XhoI enzymes and confirmed by DNA sequencing. DRC’s I-VI were assayed in the 
present study. 
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4.2.2 Expression and purification of wild type and DRC proteins 
Positive clones for each of the protein constructs were transformed into BL-21 (DE3) 
singles (Novagen) and stock cultures were prepared from fresh colonies grown in 3 ml 
LB with 100 μg/ml ampicillin for 6-8 hours at 37 oC and divided into 1.25 ml aliquots. 
Each aliquot of stock culture was inoculated into 50ml of LB media with 100 μg/ml 
ampicillin and grown at 37 oC for 2.5- 3 hours. This pre-culture was then diluted to 
OD600= 0.01-0.05 into 1 liter of LB or M9 media (12.66 g Na2HPO4.7H20, 3.0 g 
KH2PO4, 0.5 g NaCl, 1.0 g NH4Cl, 0.2 g MgSO4, 20 μl CaCl2 per liter + 3g glucose in 50 
ml H2O (autoclaved separately)). The cultures were then grown for additional 2.5-3 hours 
or until OD600 = 0.5-0.8 and induced with 0.5mM of IPTG (Isopropyl beta-D 
galactopyranoside). Protein expression was allowed to proceed by growing the cultures at 
37 oC for 3.5 hours or at 16 oC overnight. The cells were then harvested by centrifuging 
the cultures at 7000 rpm using JLA-8.1 rotor in Beckman Avanti J-20 XP centrifuge. The 
cell pellet was resuspended in 40 ml of  Ni-NTA binding buffer (20mM Tris pH 8.0 
(Sigma), 0.3M NaCl, 5mM Imidazole (Sigma), 10 % Glycerol ( Fisher or Sigma), 2mM 
beta-mercapto ethanol (Sigma)) and flash frozen in liquid nitrogen or immediately 
proceeded with sonication. Frozen biomass was thawed and sonicated using Branson 
Sonifier (VWR) for 5 x 2’ at 50% duty cycle and output 6. The lysate was then cleared of 
the membranes and other insoluble cell debris by ultra-centrifugation at 45,000 rpm for 1 
hour in Ti-50.2 rotor in Beckman ultra-centrifuge. The centrifuged lysate was 
immediately applied onto HisTrap FF column (Amersham biosciences) pre-equilibrated 
with 100 ml dH2O and 50-100 ml Ni-NTA binding buffer at 4 oC. MgCl2 and Tween 20 
[123, 130], were avoided in this study (unless otherwise mentioned) as they were 
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observed to result in protein aggregation and precipitation during subsequent steps 
(James Ames personal communication, present study). Protein sample bound to the 
column was washed extensively with 150-200 ml or Wash buffer (Binding buffer + 0.2% 
Tween 20) and then with ~500 ml of binding buffer. The proteins were then eluted using 
elution buffer (Binding buffer + 0.3 M imidazole) at a flow rate of ~2.8 ml/min. The 
eluted protein sample was then dialysed overnight at 4 oC in 2 liters of Buffer A (20 mM 
Tris-HCl pH 7.4, 1mM EDTA, 10% glycerol, 2mM DTT). The dialysate was filtered and 
applied onto a Hi-Trap DEAE column (Amersham  biosciences) pre-equilibrated with 
Buffer A at room temperature or 4 oC. After the OD 280 of the flow-through is < 0.001 
the bound protein is eluted in gradient with 0-100 % Buffer B (Buffer A + 0.6 M KCl) 
over 150 ml at a flow rate of 5ml/min. The DEAE eluted protein fractions were processed 
individually for electrophoretic mobility shift assay (EMSA) or pooled together where 
mentioned. Ni-NTA eluates were pooled and dialysed against 20 mM Tris-HCl pH 7.4, 
1mM EDTA, 10% glycerol, 100mM Nacl, 2mM DTT, overnight at  4 oC before they 
were used directly for EMSA. The highest concentrated protein fraction was either 
concentrated to ~150 μM using Amicon 15 ml centrifugal concentrators or directly used 
for gel-filtration experiments. Where mentioned batch purification of protein samples 
was done by applying the sonicated cell lysate of 500 ml cell culture resuspended into 20 
ml binding buffer made into 2 x 10 ml aliquots, onto Ni-NTA superflow resin (Qiagen) 
pre-equilibrated with Ni-NTA binding buffer (see above) by iterative incubations of 10’ 
and spinning for 6’ at 4 oC. 3 ml of resin was first spun at 4,000 xg at 4 oC and washed 
with water and binding buffer with 3 iterations of incubation and spinning. Washing and 
elution were done using same buffers described above. Three washes with 10 ml wash 
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buffer containing 0.2 % tween 20, followed by 5 washes with binding buffer. After 
spinning the final wash solution, the supernatant was decanted and protein sample was 
eluted using 2 ml elution buffer.  
4.2.3 Western blotting analysis on DREAM 
DREAM protein fractions eluted from DEAE column were assayed by western blot using 
anti-DREAM antibody (rabbit polyclonal anti-DREAM, SC-9142, Santacruz biotech). As 
a positive control recombinant DREAM, as a 51 kda GST fusion protein (sc4520-WB) 
was  purchased from Santacruz biotech. One microliter of protein sample each from 
DEAE fractions #10, #11, #12 and #13 with protein concentrations 12, 20, 47, 68 μM 
respectively and two microliters of 100 μg/ml control  protein sample (GST-fusion 
protein) were loaded onto 12% SDS PAGE-gel run in duplicates for 1 hour using NuPage 
gel system (Invitrogen) at 110 V. At the end of the run, one of the gel was stained using 
GelCode Blue (Biorad) and the other was used for performing western transfer. Western 
transfer was performed using Trans- Blot Semi-Dry apparatus from Biorad for half hour 
onto nitocellulose membrane preincubated with transfer buffer (25mM Tris, 192mM 
glycine, 20% methanol) for 30 min. The transfered membrane was then incubated with 
primary antibody (rabbit polyclonal anti-DREAM) diluted 1/800 in blocking buffer 
(75mM phosphate buffer pH 7.2, 68mM NaCl supplemented with 0.1% tween 20 and 5% 
skim milk powder) for 1 hour at room temperature.  The membrane was then washed 
with PBS-T (75mM phosphate buffer pH 7.2, 68mM NaCl supplemented with 0.1% 
tween 20) thrice for 10 min duration each time followed by incubation with secondary 
antibody (goat anti-rabbit IgG conjugated with Horse radish peroxidase) for 30 min at 
room temperature. Detection was performed using Super Signal West Dura kit (Pierce 
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biotech inc.) following manufacturer’s recommendations. The blots were then exposed 
for 2 min to Biomax light chemiluminiscent screens (KODAK) and processed using 











Table:4-1: Oligonucleotide primers used for generating DREAM-Recoverin chimeras (DRC’s). First 
primer in each case is the forward primer. NdeI sites (CATATG) in the forward primers are highlighted in 
bold and underlined, XhoI sites (CTCGAG) bold, italicized and underlined. 
4.2.4 NMR spectroscopy 
Samples for NMR analysis were prepared by dissolving 15N-labeled DREAM-C or each 
of the DRC- chimeras or Recoverin (0.2–0.5 mM) in 0.3 ml of a 95% H2O/5% [2H]H2O 
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solution containing 10 mM [2H11]Tris (pH 7.4), 5 mM [2H10]dithiothreitol, 50 mM KCl, and 
either 5 mM EDTA (apo), 5 mM MgCl2 (Mg++-bound), or 5 mM CaCl2 plus 5 mM MgCl2 
(Mg++/Ca++-bound). All NMR experiments were performed at 32 °C on a Bruker Avance 
600-MHz spectrometer equipped with a four-channel interface and triple-resonance probe 
with triple-axis pulsed field gradients. The 15N-1H HSQC spectra were recorded on 
samples of 15N-labeled proteins (in 95% H2O, 5% 2H2O). The number of complex points 
and acquisition times were: 256, 180 ms (15N (F1)), and 512, 64 ms (1H (F2). 
4.2.5 Size exclusion chromatography 
Determination of the molecular weight of the purified DREAM-C and the DRC’s in 
solution was carried out on a Superdex 200 HR 10/30 column (Amersham Biosciences) at 
room temperature, in the buffers containing 10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 5 
mM MgCl2, 1 mM dithiothreitol, with 1 mM EGTA for Ca++- free samples and with 5 mM 
CaCl2, for Ca++- bound samples. 0.1 ml of protein samples (protein concentration 150 μM 
except in the case of DRC-II , in which case the protein sample was difficult to 
concentrate and hence was used at ~40 μM, see fig.4-6B) was loaded onto the column 
and allowed to run at a flow rate of 0.5 ml/min. Low protein concentration used may, 
however, prevent dimer formation if the dimerization affinity is low . Apparent molecular 
weights were calculated using a standard curve of Ve/Vo versus the log of the molecular 
masses of standard proteins: -amylase (200 kDa), Bovine serum albumin (67 kDa), 
myoglobin (17 kDa), and cytochrome c (12 kDa). Vo is a void volume obtained using blue 
dextran (2000 kDa), and Ve is a volume of elution. The value of Ve/Vo is inversely related 
to the molecular weight of the migrating species. Thus, for DREAM-C SEC, previous 
studies in the lab showed that calcium-free DREAM-C exists as monomer irrespective of 
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protein concentration DEAE fractions were directly applied onto the column. However, 
calcium-bound DREAM-C was found to exist as a monomer at concentrations less than 
or equal to 50 μM. At concentrations greater than 50 μM DREAM-C exists as a dimer, as 







Figure 4-2: Oligomerization of DREAM as a function of protein concentration on SEC. Ve/Vo (see section 
4.2) for DREAM-C in the presence and absence of Ca++ plotted against increasing protein concentration on 
X-axis shows Mg++-DREAM-C being monomer irrespective of protein concentration, but Ca++-Mg++-
DREAM-C forming dimer starting from ~50 μM. Figure courtesy: Masanori Osawa. 
 
Increased dimerization with increase in protein concentration might indicate a low 
affinity dimerization of DREAM protein. Hence, protein samples were concentrated to 
~150 μM in the calcium bound form using Amicon centrifugal concentrators before 
application onto gel-filtration column. Precipitates resulting from the concentration of 
samples were removed by centrifugation at 14,000 rpm on bench top centrifuge. Protein 
concentrations were estimated using extinction coefficients obtained by using ProtParam 
tool on Expasy molecular biology server (http://us.expasy.org/). The values (in units of 
M-1, cm-1 at 280 nm) are DREAM-C & DRC-V: 14565; DRC-I: 16960; DRC-II: 21555; 
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DRC-III:20065; DRC-IV: 19940; DRC-VI:22460.All the samples were centrifuged at 
>10,000 xg for 10 min at 4 oC before applying onto gel-filtration column. 
4.2.6 Electrophoretic mobility shift assay 
Synthetic oligonucleotide (10pmol) (Integrated DNA technologies, IA) representing the 
sense strand of DRE (5'-GAAGCCGGAGTCAAGGAGGCCCCTG-3') of human 
prodynorphin [74, 123, 130] or of c-fos (5'-CTGCAGCGAGCAACTGAGAATCCA 
AGAC-3' ) was 5’-end labeled using γ-P32- Adenosine triphosphate (GE healthcare) 
with T4 polynucleotide kinase (Takara Bio) as per manufacturer’s recommendations. The 
labeled sense strand was then annealed with 4-5 fold excess of respective unlabeled anti-
sense strand (dyn-DRE-AS = 5'-CAGGGGCCTCCTTGACTCCGGCTTC-3', c-fos-
DRE-AS= 5'-GTCTTGGATTCTCAGTTGCTCGCTGCAG-3') in annealing buffer 
(30mM HEPES-NaOH pH 7.5, 60mM NaCl) by heating to 99 °C for 3’ and then 
incubating at 65 °C for 20’ followed by slow cooling at room temperature 3-5 hours or 
overnight. Unincorporated radionucleotides were then removed using Microspin G-25 
columns (GE healthcare) and specific activity was measured using liquid scintillation 
counter (Perkin-Elmer).  
Protein samples eluted from the DEAE column were used, directly, for binding reactions. 
100 fmol of labeled double stranded DRE was added to EMSA reaction mixture 
comprising 12-75 μM protein sample, 10 mM HEPES, pH 7.9, 8 mM MgCl2, 0.1 mM 
EDTA, 2 mM dithiothreitol, 0.05 unit/ml (1 A260 unit = 50 μg) of poly(dI-dC) 
(Amersham Biosciences), and with or without 10 mM CaCl2. The reactions were 
incubated at 4 °C for 1 hour. Protein-DNA complexes were resolved in 5% non-
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denaturing polyacrylamide/0.25 x TBE/1% glycerol gels at 200 V for 2 hours min in 0.25 
x TBE and 0.5 mM MgCl2 running buffer. Gels were then dried and exposed to phosphor 
screens (GE health care) or X-OMAT X-ray films (KODAK) and developed on STORM 
system or KODAK film processor. EMSA bands were quantified using ImageQuantTL 
(GE health care) by dividing the counts from the band shift with the sum of counts in the 
shifted band and the duplex probe at the bottom of the gel. 
Previously reported incubation of 5 hours at room temperature [130] resulted in complete 
degradation of the probe with exo- and endonucleases. Hence, where mentioned binding 
reactions were incubated at 4oC overnight. Competition with cold specific and non-
specific probes was done by co-incubating unlabeled double stranded oligonucleotides as 
mentioned with the EMSA reactions. Unlabeled double stranded DNA elements used in 
competition experiments were c-fos-DRE (see sequence above), DREmut5 (5’-
GAAGCCGGAATC AAGGAGGCCCCTG-3') and c-AP1-sense strand (5'-
AAGCTTGCATGACTCAGACAG-3'). In experiments testing salt dependence on band 
shift, appropriate amounts of salt was added to bring the initial DEAE fractions on par 
with later DEAE fractions. Salt concentrations of DEAE fractions were approximated 
based on the position of protein elution on the salt gradient.  
Supershift experiments were performed, by co-incubating 15 μg each of anti-his antibody 
(Genscript), anti-DREAM antibody (FL-214, Santacruz) and anti-HNF4 antibody 
(Santacruz) with the DNA binding reactions. 
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4.3 Results and Discussion  
4.3.1 DREAM-Recoverin chimeras retain stable tertiary structure
Two-dimensional NMR spectroscopy was performed on each of the DREAM-Recoverin 
chimeras in the presence of calcium and magnesium to ascertain the stability of protein 
structure. Previous studies on wild-type DREAM-C using 1H-15N HSQC NMR showed 
that addition of calcium and magnesium dramatically improves stability of DREAM 
protein under NMR conditions. All the DREAM-Recoverin chimeras (DRC’s) showed 
well-dispersed spectra similar to wild type with uniform intensities (fig.4-3), indicating 
the presence of stably folded tertiary structure in each case. Each of the peaks in the 
spectra represents a single amide proton in a unique chemical environment, providing an 
overall fingerprint of the protein conformation. The observed spectra of each of the 
chimeras reveal that the chemical shifts of both substituted and unsubstituted residues are 
largely unperturbed in the chimeric proteins, particularly for the downfield shifted and 
non-overlapping resonances. For example, the downfield shifted peak of DRC-I 
(highlighted red in Fig. 4-3) assigned to an amide resonance of EF-3 (Gly 180) has a 
chemical shift very similar to that of the corresponding residue of EF-3 in recoverin (Gly 
115). Similarly, for DRC-II the downfield shifted peak assigned to EF-2 has a chemical 
shift similar to that of the corresponding residue of EF-2 in recoverin (Gly 79).  The 
preserved chemical shifts for the recoverin-substituted residues and well-dispersed NMR 
spectra imply that the structure of each substituted EF-hand must remain structurally 
intact in all the chimeras, making them suitable for functional assays using EMSA to test 
for their individual DNA binding properties.  
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Figure 4-3: Two-dimensional N- H HSQC NMR spectra of calcium bound protein samples of wild type-
DREAM-C (WT), Recoverin, 
15 1
DRC-I, DRC-II, DRC-III, DRC-IV, DRC-V, DRC-VI. Each protein sample 
was uniformly labeled with nitrogen 15, and spectra were recorded at 600-MHz 1H frequency. DRM: wild 
type DREAM-C; Rec: wild type recoverin. Figure courtesy: James Ames. 
4.3.2 Oligomerization properties of DREAM-recoverin chimeras vs. Ca++
The oligomerization state of DRC proteins were assessed using size exclusion 
chromatography (SEC) (Figs 4-4 to 4-7). Molecular weights were estimated using the 
standard curve plotted using beta amylase, bovine serum albumin, myoglobin and 
cytochrome c standards (Fig.4-4C). For suitable comparison, wild type DREAM-C and 
recoverin protein samples were run on SEC as well. Consistent with previous studies (see 
2.2.2), DREAM-C eluted as a monomer in Mg++-bound, calcium-free state and as dimer 
(consistent with previous observations of Masanori Osawa, fig.4-2) in calcium-bound 
state (Fig. 4-4). Although the estimated molecular mass of calcium-bound DREAM-C 
based on the Ve/Vo values was 38 kda, it was interpreted to be a dimer. Previous studies 
in the lab, using dynamic light scattering showed that at 87 μM protein concentration 
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calcium-bound DREAM-C showed a hydrodynamic radius of 3.13 nm that corresponds 
to 45.7 kda [130]. Thus, the reason for lower apparent mass of Ca++-DREAM-C may be 
due to a dynamic exchange between monomeric and dimeric DREAM-C while passing 
through the size column. Recoverin on the other hand eluted as a monomer in both 
calcium-free and calcium-bound states (Fig.4-5). Estimated molecular weights of DRC’s 
along with a summary of SEC results are shown in Table 4-2. The difference in peak 
heights of SEC elutions of DRC proteins is due to concentration of the protein samples to 
~150 μM in the calcium bound state but not in the calcium free state (for details see 
section 4.2.5). 
Briefly, all chimeras (except DRC-II, DRC-IV and DRC-V) are monomeric in the Mg++-
bound state similar to wild type. Mg++-bound forms of DRC-II and DRC-IV are dimeric 
and DRC-V forms large protein aggregates. In the Ca++-bound state, all chimeras (except 
DRC-IV and DRC-V) are predominantly monomeric, in contrast to Ca++-induced 
dimerization of wild type. The calcium-bound DRC-II exhibits a low molecular weight 
species (fig.4-6B) that can only be explained by calcium-induced changes in the protein 
that may lead to the apparent slow mobility on the size column relative to calcium-free 
form. Specifically, binding of calcium to DRC-II might result in conformational changes 
in DRC-II protein that promote its interaction with the column resulting in the apparent 
slower mobility. The apparent aggregation of DRC-V in both Mg++-bound and Ca++-
bound states may be related to removal of the C-terminal helix, perhaps leading to 
exposure of hydrophobic residues in EF-3 and EF-4 that otherwise would be sequestered 
by the C-terminal helix as seen in the structure of KChIP1. However, considering the 
effect of protein concentration on DREAM oligomerization in the presence of calcium, 
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similar experiments on each of the chimeras in the absence and presence of calcium 
would provide an estimate of the dimerization affinity of each of the chimeras. 
A  B.  
C.  
 
Figure 4-4: Size exclusion chromatograms of DREAM-C in calcium-free (A) and calcium-bound (B) forms. 
Protein concentrations were 80 μM in (A) and 150 μM in (B). (C) Standard curve for molecular mass 
determination created using beta amylase (206 kda), BSA (66 kda), Myoglobin (17 kda) and cytochrome c 
(12 kda) with molecular masses of standards indicated at each data point on standard curve. Void volume 
Vo was obtained as 7.60526 using blue dextran (2000 kda). Ve is the elution volume of each sample. 
Estimated mass of Mg++-DREAM-C was 26.8kda; estimated mass of Ca++-Mg++-DREAM-C was 38 kda 
(less than apparent dimer molecular weight of Ca++-Mg++-DREAM-c is consistent with previous studies 

























A.                                                                                            B           .     
Figure 4-5: Overlaid size exclusion chromatograms of calcium-free (blue) and calcium-bound Recoverin 
(protein concentration ~120 μM) (A). SDS PAGE of recombinant Recoverin (unmyristoylated) used for 
running SEC, Molecular weight markers from top represent 97, kda, 66, kda, 45 kda, 31 kda, 21 kda, and 
14 kda. Recoverin migrates at ~25 kda. Estimated molecular mass of recoverin in SEC was 26.8kda.
 
A.  B.  
Figure 4-6: Overlaid size exclusion chromatograms of calcium-free and calcium-bound DRC-I (A), DRC-II 
(B). Blue traces represent calcium-free state, pink and red traces represent calcium-bound state. Estimated 


















C.  D.  
 
Figure 4-7 : Overlaid size exclusion chromatograms of calcium-free and calcium-bound DRC-III (A), 
DRC-IV (B), DRC-V (C), and DRC-VI (D). Blue traces represent calcium-free state, pink and red traces 




Table 4-2: Summary of SEC results. All descriptions follow the time of elution pattern (from left to right on 
X-axis). Columns from left to right labeled as 1) standards, Molecular weight in kilo daltons, log10 
molecular weight, elution volume, Ve/Vo (Vo measured by blue dextran= 7.65), Estimated Molecular 
weight from Ve/Vo using standard plot (Fig 4-4), comments. © indicates concentrated DREAM-C sample to 
150 μM. 
4.3.3 Magnesium inhibits dimerization of DREAM in the absence of calcium 
In the absence of calcium, wild type (fig. 4-4), DRC-I (fig.4-6A), DRC-III (fig. 4-7A), 
and DRC-VI (fig. 4-7D) proteins, all exist in a monomeric state, whereas DRC-II (fig.4-
6B) and DRC–IV (fig.4-7B) are not monomeric. The monomeric chimeras each contain 
the high affinity magnesium-binding site from the EF-2 of DREAM protein. Conversely, 
replacing EF-2 of DREAM with that of recoverin in DRC-II (Fig.4-6B) and DRC-IV 
(Fig.4-7B) results in dimeric or higher order oligomers, suggesting that magnesium 
binding to EF-2 stabilizes the monomeric form of the protein, which was also observed in 
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the case of wild-type DREAM protein (see section 2.1 and [123]). In the case of DRC-V 
(Fig. 4-7C), since the C-terminal helix is missing, the protein may have many of its 
hydrophobic residues exposed that may promote the observed oligomeric states in the 
presence or absence of calcium.  
4.3.4 Head-to-tail Dimerization of DREAM  
All the chimeras (except DRC-IV and V) are monomeric in the calcium-bound state (Fig 
4-7), in contrast to the dimeric calcium-bound wild type (Fig.2-10). The results from the 
SEC of DRC-I and DRC-II suggest that Ca++-induced dimerization can be abolished by 
perturbing any pair of EF hands from the N-terminus or the C-terminus of the DREAM 
protein, which implies that the dimer interface may not be localized to a particular EF-
hand, but instead may span all four EF-hands. The SEC data of DRC-IV show that the 
presence of a single EF hand (EF-1) from DREAM protein results in calcium-induced 
oligomerization. However, lack of a complete data set from chimeras with individual EF-
hands of DREAM in isolation, and the possibility of the calcium-induced olimerization 
effect stemming from the inherent instability of the chimeric protein preclude such a 
definite conclusion. Crystal structure of KChIP1 [128], a closely related protein to 
DREAM, shows a head to tail dimer formation in the presence of calcium. Thus, it is 
plausible to speculate that DREAM may also form a head-to-tail dimer that involves 
intermolecular contacts between EF-1 and EF-4 plus EF-2 and EF-3. However, the SEC 
results of DRC proteins do not rule out a head-to-head dimer formation. A model for 
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Figure 4-8: (A) Model for head-to-tail DREAM dimer in calcium bound state, based on KChIP1 crystal 
structure [128]. Each of the ellipses represents an EF-hand – Rose: EF-1, Tan: EF-2, light yellow: EF-3, 
pale blue: EF-4. Dimerization occurs via intermolecular interactions of EF-1 with EF-4 and EF-2 with EF-3. 
(B) Crystal structure of calcium bound KChIP1 [128] with EF hands colored- EF-1: red; EF-2: light 
yellow; EF-3: light orange; EF-4: magenta. Subunits are named by the color of N and C terminal helices 
(green and cyan). Metal coordinating loops are labeled. EF-1, EF-2, EF-3, EF-4 and CH (C-terminal helix) 
denote green subunit and EF-1’, EF-2’,EF-3’, EF-4’, CH’ denote that of cyan subunit. Dark yellow arrows 
show leucine zipper present in EF-2 (L115-L119). 
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4.3.5 Recoverin does not bind DNA 
Electrophoretic mobility shift assays were employed to probe whether recoverin exhibits 
calcium-sensitive binding to DRE similar to that of DREAM. The EMSA with 
recombinant recoverin in the presence and absence of calcium is shown in Fig.4-9.  No 
detectable band shift was observed for recoverin (Fig.4-9) using the same conditions used 
to see a band shift with DREAM [74, 130].  Hence, recoverin does not bind DRE under 





Figure 4-9: EMSA with recombinant recoverin incubated with 5nM of γ-
P32 labeled dyn-DRE in the presence or absence of calcium as indicated. 




4.3.6 DREAM co-purifies with nuclease activity  
Initial EMSA experiments performed on wild type DREAM protein (referred 
interchangeably as DREAM-C, the C-terminal portion of DREAM comprising four EF 
hands) aimed at replicating previously published results [74, 130]. This was an essential 
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prerequisite, to ascertain DREAM’s calcium-sensitive DNA binding behavior in my 
hands before we could proceed with analyzing the DREAM-Recoverin chimeras in more 
detail.  Initial EMSA studies on DREAM protein by Carrion et al. (1999) used full length 
recombinant DREAM and 5’- P32 end-labeled DRE probe to characterize DREAM-DNA 
interaction. However, since the full-length recombinant protein was prone to aggregation 
(James Ames, personal communication) and very difficult to purify, a truncated protein 
comprising amino acids 65-256 (DREAM-C) was used in previous studies from the lab. 
DREAM-C binds functionally to DRE with about 2-fold lower affinity than full-length 
DREAM ([130], fig.1-9). The previous EMSA study using DREAM-C in Fig. 1-9 used a 
Cy5 flourophore to assay DNA binding. In the present study, 5’- P32 end-labeled DRE 
probe was used to perform EMSA with affinity-purified DREAM-C (see section 4.2.6). 
However, incubation of the DNA binding reactions at room temperature for 5 hours, 
similar to the previous studies in fig.1-9 [130], resulted in complete degradation of radio-
labeled probe; as a result, no band shift was observable (fig.4-10A). This result was at 
odds with previously reported EMSA results for DREAM-DRE interaction [130]. 
The lack of band shift in my experiments (Fig. 4-10) could be due to non-availability of 
duplex DNA probe due to nuclease activity co-purifying with DREAM, as evidenced by 
the degraded probe at the bottom of the gel in Fig. 4-10. Since, earlier studies [130] were 
carried out using a fluorescent label (Cy5), the presence of the bulky fluorophore might 
have protected the labeled DRE from nuclease degradation.  
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Figure 4-10: EMSA with Ni-affinity purified DREAM-C to test DREAM-DRE interaction. (A) EMSA with 
affinity (Ni-NTA chromatography) purified DREAM-C (Ni-DREAM) at indicated concentrations. Protein 
samples were diluted from Ni-dialysate (see 4.2.2). Protein concentration 285 μM. Asterisk indicates boiled 
probe to test the migration of single strand probe. Arrowhead indicates position of double stranded DNA, 
arrow points to the position of single strand probe. Degraded probe is found at the bottom from lane 3 
onwards-position.indicated by ‘#’. (B) SDS-PAGE showing the steps in protein purification. Molecular 
weight markers from top represent 97, kda, 66, kda, 45 kda, 31 kda, 21 kda, and 14 kda. 
In addition to nuclease degradation, other factors including protein denaturation and/or 
the presence of protein impurities might also have prevented the occurrence of a gel-shift. 
To overcome the nuclease problem, I added salmon sperm carrier DNA into the DNA 
binding reactions at different amounts (1 μg or 1.6 ng in 20 μl volume) and incubated the 
reactions at 4oC instead of room temperature. The rationale is that carrier DNA and low 
temperature would prevent the nucleases in the reaction from acting on the radio-labeled 
probe. The reasoning behind 5-hour incubation in the earlier studies was that recombinant 
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DREAM protein tends to form aggregates and hence the long incubation time provided 
adequate time for the slow dissociation of aggregates into active free species that would 
then give rise to the band shift (James Ames personal communication). Thus, incubating 
overnight at 4oC would serve a similar purpose. While this was successful in preventing 
the probe degradation, there still was no band shift detected (fig 4-11). 
A.  B.  
Figure 4-11: Effect of carrier DNA (salmon sperm DNA) on EMSA with DREAM-C. Carrier DNA 
addition prevents nuclease digestion of radio labeled probe but fails to promote DREAM-DRE interaction. 
Freshly prepared Ni-dialysate diluted to indicated protein concentrations was incubated with (A) 1μg (B) 
1.6 ng amounts in 20 μl volume and incubated at 4oC overnight. Arrows indicate degradation products. 
Addition of calcium does not influence migration of probe (lane 2 in (A)). 
The lack of a gel-shift in Fig. 4-11 is likely due to binding of DREAM protein to the 
carrier DNA. The core sequence recognized by DREAM was reported to be “GTCA” 
[179]. By probability, the occurrence of this sequence in a random double-stranded DNA 
is 44, or 1 in 256 bases. Thus, use of carrier DNA did not help in observing DREAM-
DRE interaction. As an alternative approach, to remove the nuclease activity from 
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DREAM protein sample, I opted to use DEAE-anion exchange chromatography to purify 
recombinant DREAM (see section 4.2.2). 
4.3.7 Heterogenous species of DREAM bind differentially to DNA 
Further purification of recombinant DREAM-C protein samples was performed by 
applying the eluate from Ni-affinity column onto an anion exchange (DEAE) column. 
When each of the DEAE eluted fractions was assayed for DNA binding activity by 
EMSA, it was observed that the initial fraction (#14) (fig.4-12A, lanes 2 and 3, indicated 
by ‘*’) exhibits calcium-sensitive DNA binding similar to the binding described in 









Figure 4-12: EMSA and SDS PAGE with DEAE purified fractions of DREAM-C. (A)EMSA: Lane 1 
represents probe only without protein. Presence of 10mM calcium is indicated at the bottom. Protein 
concentrations are 58 μM, 77 μM, 46 μM for #14, #15, #16 respectively. Percentage of DNA bound (upper 
band only) was quantified to be 11.5% and 5.6% in lane numbers 2 and 3 respectively. Asterisk indicates 
band shift that is disrupted by calcium. Block arrow in (A) indicates position of band shift corresponding to 
DREAM’s altered activity. (B) SDS PAGE showing the protein at the end of each purifcation step. Dashed 
arrows point to high molecular weight species in DEAE #16. 
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However, the later fractions (#15 and #16) show an additional band (indicated by arrow 
in fog.4-12A) that migrates faster and was also observed in the earlier published studies 
[74, 125, 130, 179] (also see fig.3-1). The second band shift shows enhanced signal in the 
presence of calcium (fig.4-12A, lanes 4-7).  
Thus, the additional purification of DREAM-C restored its DNA binding activity as 
previously reported [74, 130]. However, it was indeed intriguing to observe that the later 
fractions, despite the presence of purified DREAM-C (as seen in the SDS PAGE, fig.4-
12B) do not show the band shift similar to the initial fraction. The lack of band shift with 
protein from later fraction raises the question if the band shift obtained is DREAM-
specific (which would be considered later in the study, section 4.3.11). Assuming that the 
band shift is due to DREAM, the simplest interpretation of segregation of the two 
different activities of the protein, upon DEAE purification, would be that recombinant 
DREAM protein exists in multiple conformational states that differentially recognize 
DNA. Before proceeding to characterize the later fractions further, I decided to check the 
specificity of the DNA binding activity from the initial fraction.  
4.3.8 Recombinant DREAM-C binds specifically to DRE 
To determine whether the DREAM-DRE interaction as seen in fig. 4-12A was sequence-
specific, I performed competition experiments by adding unlabeled double-stranded 
probe oligos in excess to the DNA binding reactions, while performing EMSA of wild 
type DREAM-C. Specificity was determined by observing reduction (due to competition) 
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in observed band shift as a function of the addition of excess of unlabeled oligos 
corresponding to DRE, DREmut5 and c-AP-1.  
The initial fraction behaved consistent with previously published results from the lab 
[130]. In the competition experiments using unlabeled probe DNA in EMSA, cold c-fos 
DRE abolished band shift as expected (fig.3-1). Likewise, the c-AP1 oligo, which 
contains the core DREAM binding element ‘GTCA’ in the anti-sense strand also 
abolishes the DREAM-DRE band shift in EMSA (fig.4-12). In contrast DRE-mut5, 
which has the critical single base, G → A, substitution (shown in fig.3-1), failed to 
abolish DNA binding as shown previously (fig.3-1, [179]) 
 
Figure 4-13: Test for the specificity of DREAM-DNA interaction EMSA of purified (DEAE fraction #13) 
DREAM-C with competition from 15 fold excess of cold probes, as indicated (c-fos DRE, DREmut5 or 
cAP-1). A quantified competition assay is presented below. Protein concentrations used are 49 μM. Control 
indicates DNA binding reaction with no calcium, or unlabeled probe. +10mMCa++: control + calcium, cold-
DNA (c-fos-DRE), m5: mut5 DRE (mutated dyn-DRE).  
In summary, our initial attempt to reproduce the band shift indicating DREAM-DNA 
interaction as reported previously did not yield expected results. However, the inclusion 
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of an additional purification step resulted in the observation of a calcium-sensitive gel-
shift consistent with the studies mentioned above. The band shift obtained was sequence 
specific as indicated by oligo competetion assays. Interestingly, EMSA analysis of 
individual DEAE eluted fractions of recombinant DREAM revealed, in addition to the 
previously characterized binding activity, a calcium-enhanced band shift that was 
exhibited only in the later fractions (#15 and #16 in fig.4-12A) from the DEAE column. 
This band shift might reflect a novel DNA binding activity of DREAM or might be 
explained by a contaminant protein from E.coli. Additional experiments were designed to 
determine the source of this new binding activity. 
4.3.9 Recombinant DREAM exists in multiple conformational states 
A fortuitous observation strongly suggests that the additional band shift is also due to 
DREAM-C activity. Figure 4-14A shows EMSA of freshly purified, DEAE eluted 
DREAM-C protein along with 6-month old DREAM protein sample stored at 4oC. The 
freshly prepared protein sample shows a high molecular weight band shift that is 
calcium-sensitive (compare with fig.4-12A) in terms of recognizing DNA. While a 
calcium-enhanced, lower molecular weight band shift is observed in the fresh protein 
sample (fig.4-14A) similar to later fractions in fig.4-12A, it is present at much lower level. 
After 6 months, identical sample in fig.4-14A shows dramatically different binding 
properties resulting in a conversion from the high molecular weight, calcium-sensitive 
band shift to low molecular weight, calcium-enhanced band shift. The interconversion of 
one DNA binding activity to the other provides strong evidence for protein 




Figure 4-14: Transformation of DREAM protein activity with age. (A) EMSA of DREAM protein with 
DRE probe at two differnt time points. Left panel shows EMSA of freshly purifed protein. Right Panel 
shows the same sample as in the right stored for 6 months at 4oC. Percentage DNA bound by the fresh 
sample was quantified to be 16% and 3%respectively (upper band only). Block arrow indicates position of 
band shift corresponding to DREAM’s altered activity B) SDS PAGE of the protein sample of the aged 
protein. DREAM migrates at ~27 kda. Dashed arrows indicate high molecular weight species similar to 
those observed in fig.4-12B.
The 6-month-aged DREAM sample in fig.4-14 shows a calcium-enhanced lower band 
shift similar to the later fraction (#16 in fig.4-12A). SDS PAGE analysis of both samples 
[aged (fig.4-14B) and later fraction (fig.4-12B)] shows high molecular weight species 
that might represent oligomeric species of DREAM protein or DREAM protein 
complexed with a contaminant protein from E.coli. To ascertain the presence of DREAM 
protein, I performed western blot analysis with anti-DREAM antibody, on individual 
DEAE eluted DREAM protein fractions. The result shows that the high molecular weight 
species contain DREAM protein (fig.4-15). Furthermore, experiments using bacterial 
lysates, prepared from cells containing the empty expression vector (fig.4-17A) argue 
against the presence of a protein contaminant from E.coli. 
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Figure 4-15: Western blot of DEAE fractions with Anti-DREAM antibody. Lanes from left to right are: 
Marker, control DREAM protein (51 kda GST-fusion DREAM protein purchased from Santacruz biotech. 
was used as positive control. Freshly purified DREAM-C-DEAE fraction #10, #11, # 12, # 13. High 
molecular weight bands were observed only in later DEAE fraction but NOT earlier DEAE fractions. 
Arrow head indicates recombinant DREAM protein migrating at ~27 kda. 
 
Thus, the results from EMSA with individual DEAE fractions, comparison of freshly 
purified DREAM with aged sample, and western analysis consistently favor the existence 
of DREAM in multiple conformational states. While time can promote this 
transformation, another obvious possibility for the difference between each of the DEAE 
eluted fractions would be the concentration of salt. Recombinant protein bound to the 
DEAE column is eluted with a salt gradient from 0-100% across 150 ml with 0.6M KCl 
(see section 4.2.2). Therefore, I wished to test the effect of salt concentration on 
DREAM-DRE interaction. 
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4.3.10 Transformation of DREAM-DNA binding activity is not salt dependent 
To examine the effect of salt on the EMSA band shifts, I performed EMSA experiments 
with separate DEAE fractions wherein I increased salt concentration of earlier fractions 
and decreased (by dialysis) the salt concentration of later fractions. The aim of this 
experiment was to test if salt concentration is responsible for the transformation of the 
DREAM-DNA binding activity from a calcium-sensitive DNA binding as seen in the 
case earlier fraction fig. 4-12A to calcium enhanced binding as observed in later fractions 
in fig.4-12A and aged sample in fig.4-14A.  
Increasing the salt concentration did not perturb significantly, the DNA binding activity 
of initial fraction (#13, fig.4-16-lanes S1 and S2). However, since the later fractions do 
not show the second activity (the calcium enhanced DNA binding described above) in 
this experiment no conclusion can be made on the effect of salt on the calcium-enhanced 
lower band shift. It is also worth noting that decreasing the salt concentration in the later 
fractions (lanes under SS in fig.4-16) does not restore DNA binding similar to the initial 
fraction (lane 2, fig.4-16). Furthermore, the band shift observed in the case of initial 
fraction is sequence specific when competed with cold oligonucleotides as described in 
fig.4-13 lanes 3, 4, 5). 
Thus, it was observed that salt concentration, by itself, is not the causative factor to 
transform DREAM-DNA binding activity from calcium sensitive binding as previously 
described (see fig.3-1, early fraction in fig.4-12A) to the calcium-enhanced DNA binding 
observed in this study (later fractions in fig.4-12A and aged sample in fig.4-14A) 
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Figure 4-16: Effect of Salt on gel-shift exhibited by DEAE eluted fractions of DREAM-C. DEAE eluted 
fractions #13, #14, #15 with protein concentrations 49 μM, 87 μM and 72 μM respectively were incubated 
in the absence of Ca++ with radio labeled DRE probe. The figure shows EMSA of #13 in the absence and 
presence of unlabeled competitors in a 15 fold excess or with varying amounts of salt concentration. For 
fractions #14 and #15, the figure shows EMSA in the absence of unlabeled oligos, and with decreased salt 
concentration (SS). #13, #14 and #15 eluted at ~150 mM, ~200 mM and ~250mM salt respectively. 
Percentage of DNA bound in lane numbers 2,3,4,5,6,7,8,9,10,11 was quantified to be 29%, 31%, 11%, 
7.3%, 29%, 20%, 18%, 24%, 13%, 6.5% respectively.  Note that the probe only lane does not contain lower 
most bands that constitute products of  exo and endo nuclease (shown by thin and dense arrows 
respectively) activity. The unbound probe consists of duplex, single strand and  an endonuclease activity 
4.3.11 DRE binding activity is associated with recombinant DREAM 
To rule out the possibility of the band shift occurring due to an E.coli contaminant and to 
make sure that the observed DNA binding is indeed due to recombinant DREAM, I 
prepared bacterial lysates of strains containing the empty pET15b vector and performed 
EMSA with labeled dynorphin DRE after following the purification protocol for 
DREAM-C. The experiment was performed using a batch preparation (see section 4.2.2), 
with bacteria, containing empty vector and DREAM plasmid induced for protein 
expression. After inducing expression for 3 hours at 37oC cells from both the cultures 
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(empty vector and pet15b-DREAM-C containing bacterial cultures) were harvested, and 
processed further, as described in the methods section. DNA binding reactions were 
prepared using the Ni++- eluted protein samples for qualitative comparison. Not 
surprisingly, under identical purification and binding conditions, the bacterial lysate with 
empty vector did not show significant DNA binding but the lysates containing DREAM-
C protein showed DNA binding (Fig 4-17A). Thus, the observed EMSA band shifts are 
definitely associated with the presence of DREAM-C, although presence of a 
contaminant E.coli protein along with DREAM cannot be ruled out. However, a far-
Western analysis (that involves transfer of the protein-DNA complexes from EMSA-gel 
onto a membrane and probing with anti-DREAM antibody) should be performed to 
confirm that the radioactive band shift contains DREAM-C.  
Figure 4-18 shows the SDS-PAGE analysis of the preparations of samples used in Fig 4-
17. The purification steps in the case of empty vector lysates show that there‘s no 
detectable protein as observed by coomassie staining (fig.4-18A) consistent with the lack 
of band shift in fig.4-17A. Further, DREAM-C protein sample was free of impurities that 
can be detected by coomassie staining (fig.4-18B).  
Supershift experiments were performed to confirm the presence of DREAM protein in 
the band shifts by adding anti-DREAM or anti-His antibodies to the DNA binding 
reactions. As a negative control, anti-HNF4 antibody was also tested. However, this 
experiment did not yield any retarded bands with anti-his antibody, and yielded a smear 
with anti-DREAM antibody (4-17B). The lack of supershift with anti-His antibody 
suggests that the His-tag may be inaccessible.  A smear in the presence of anti-DREAM 
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antibody might indicate that DREAM does indeed interact with the antibody, but 
unfortunately, a negative control (antibody added without DREAM) was not performed. 
So, no clear conclusion can be made. 
A.             B.  
Figure 4-17: A) EMSA of Ni -eluates prepared from empty vector (EV) and DREAM-C plasmid 
containing bacterial lysates
++
. Lanes: 1) probe only without protein 2, 3) Ni eluate EVTMg , 4, 5) Ni eluate 
EV, 6, 7) Ni eluate DREAM-C –TMg, 8,9) Ni eluate DREAM-C. TMg indicates presence of 0.2 % tween 
20 and MgCl2 in the sonication buffer. Arrowhead indicates position of specific DRE band retarded by 
DREAM protein. Protein concentrations of DREAM are 94 μM in lanes 2 & 3 and 100 μM in lanes 4 & 5. 
(B) Supershift experiment using 15 μg each of Anti-His antibody (Genscript) (lane 1), Anti-DREAM 
antibody (Santacruz) (lane 2) and Anti-HNF4 antibody (Santacruz) (lane 3). All supershift experiments 
















              A.                                                            B. 
Figure 4-18: SDS PAGE analysis indicating progress of purification steps of A) Empty vector  and B) 
DREAM-C bacterial lysates by Ni++-affinity chromatography using batch method. Excluding markers lanes 
from left to right show aliquots from lysate, supernatant, washes 1 through 7 and  Ni- eluate. Of the eight 
washes described in the methods section aliquot from the last wash was omitted. Molecular weight markers 
from top represent 97, kda, 66, kda, 45 kda, 31 kda, 21 kda, and 14 kda. 
 
4.3.12 Summary of DNA binding experiments 
In summary, the EMSA gel-shift experiments with wild type DREAM protein in this 
study indicated considerable sample heterogeneity of DREAM protein. The early fraction 
from the DEAE elution exhibited sequence specific, Ca++-sensitive DNA binding as 
observed before [74, 130]). However, the remainder of the protein (~90% of the total) 
showed either calcium-enhanced DNA binding or no binding at all. We currently do not 
understand why the multiple DNA bands with different calcium sensitivities were not 
seen in the previously published studies, which reported only one apparent species of 
DREAM that bound to DNA only in the absence of calcium [74, 130]. One possible 
explanation for the difference is that the extra purification step (DEAE chromatography) 
used in this study has resolved and uncovered multiple protein species that previously 
were either undetected or unresolved. 
 107 
In the present study on DREAM-DRE interaction, a calcium-enhanced DREAM-DNA 
binding activity (by way of band shift position on EMSA) was observed and partially 
characterized, apart from the previously reported binding activity (fig.3-1). The puzzling 
nature of DREAM’s dual mode of interaction with DRE (upper and lower bands on 
EMSA, figs.4-12A) is best explained by conformational heterogeneity of recombinant 
DREAM, which was inferred from the analysis of DEAE resolved fractions (fig. 4-12A), 
indicated by multiple bands in western blots (fig.4-15) and evidenced by the 
transformation of aged protein samples (fig.4-14). The sample heterogeneity was 
unfortunately found to be prep-dependent as later fractions from some protein 
preparations show enhanced binding on addition of calcium (fig.4-12A). However, the 
upper band shift seen in the early DEAE fraction was highly reproducible and shown to 
be sequence specific (figs.4-12, 4-13). In all cases, the later DEAE fractions were found 
to behave differently from the earlier eluted fractions, indicative of heterogeneous species. 
While the functional significance of the lower calcium-induced band shift in Fig. 4-12 is 
currently unclear, it is possible that it may be the result of an altered conformational state 
of the protein. Recently, D’Andrea et al. (2005) showed that thapsigargin treatment, 
which blocks endoplasmic reticulum Ca++ ATPase resulting in increased cytosolic 
calcium levels, leads to increased repression of thyroid genes Pax8 and TTF2/FoxE1 by 
DREAM correlated with increased binding to DRE [120]. Furthermore, the specificity of 
DREAM-DNA interaction was confirmed by the competition experiments that 
demonstrated DREAM’s specificity towards DRE sequence as previously characterized 
[74, 130, 179]. Thus, DREAM binding to DNA under elevated calcium levels may be 
possible for which existence of DREAM in an alternative conformational state would be 
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a plausible explanation. Whether this binding is a result of DREAM-DRE interaction 
alone and not mediated by DREAM’s interaction with other transcription factors remains 
to be established.  
Heterogeneous DNA binding activities of DREAM could also be explained with an 
analogy to prion protein hypothesis wherein a small fraction of altered conformation may 
nucleate the conversion of native protein into its alternative form [212]. Future studies 
could test this hypothesis, by adding a small amount of protein sample from later eluted 
DEAE fractions into the earlier fractions and observe for any changes in its activity. In 
addition, to ascertain the functional nature of calcium enhanced binding to DNA (lower 
band shift) dominant negative mutants of DREAM that are completely disabled for 
metal-binding (refer section 2.1) could be used to perform EMSA. If the lower band is 
still observed with the mutants defective for calcium binding, then it could be deemed as 
a calcium-binding independent property of DREAM. Further, the specificity of this 
interaction could be tested by using unlabeled specific and non-specific probes for 
competition experiments. 
4.3.13 EMSA analysis on DREAM-Recoverin Chimeras (DRC’s)
In view of the apparent sample heterogeneity, all subsequent EMSA experiments on the 
chimeras were performed using two types of sample preparations: 1) pooled protein 
fractions eluted from DEAE chromatography to ascertain qualitative DNA binding and 2) 
individual and separated DEAE fractions to observe any calcium-induced effects. 
However, the interpretations of these results would be speculative, due to apparent 
uncertainity of multiple DREAM species and lack of knowledge on whether altered DNA 
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recognition of a chimera is due to disruption of binding site or due to its enhanced 
propensity to adopt alternative conformations. 
When pooled DRC protein samples were used for EMSA experiments, all the chimera 
proteins except DRC-IV exhibited DNA binding similar to that of wild type (Fig 4-19). 
DRC-IV showed abolition of DNA binding upon addition of calcium, similar to that 
observed with wild type DREAM in previous reports [74, 130]. Collectively, since all the 
chimeras exhibit DNA binding, this would suggest that the DNA binding region in 
DREAM might be delocalized among the four EF-hands and not confined to a distinct 
structural region. However, given the variability and ambiguity of the EMSA results 
combined with circumstantial evidence that the observed EMSA band actually represents 
DNA binding to DREAM, it is certainly possible that the EMSA bands in this study will 
also represent some type of artificial binding to an E. coli contaminant protein.  If this 
were the case, it could explain some of the prep-dependent artifacts in these studies such 
as the lower spurious bands as well as the calcium-insensitive EMSA bands.  However, 
the uppermost EMSA band (associated with the early DEAE fractions: #14 in Fig. 4-
12A) was shown in this study to be sequence specific and calcium sensitive, in the case 
of wild-type DREAM, as seen in previous studies [74, 123] (Fig.4-12), arguing that at 
least this band might represent functional DNA binding by DREAM.  
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Figure 4-19: Electrophoretic mobility shift assay using pooled DEAE fractions of wild type DREAM-C and 
Dream-recoverin chimeras. Presence of 10 mM Ca++ is indicated at the bottom. In the case of DRC-VI, Ni- 
eluate was directly used for EMSA. Protein concentrations in all the lanes is ~65 μM. 
 
Electrophoretic mobility shift assay of individual DEAE fractions of each of the chimeras 
and their SDS PAGE figures are shown in figures 4-20 through 4-25 respectively. The 
EMSA data for DRC-I (Fig. 4-20), -III (Fig. 4-22) and -VI (Fig. 4-25) are very similar to 
that described above for wild type (Fig. 4-12) and suggest that these chimeras exhibit at 
least some form of DNA binding, consistent with the EMSA data above on the pooled 
fractions in Fig. 4-19. However, the DEAE resolved EMSA data for DRC-II (Fig. 4-21) 
and DRC-IV (Fig. 4-23) both lack the calcium-responsive EMSA band associated with 
the early DEAE fraction (e.g. fraction #14 for wild type in Fig. 4-12; #10 for DRC-II; and 
#11 for DRC-IV). Recall, that this EMSA band for wild type was also shown to be 
sequence specific (Fig. 4-13).  Since both DRC-II and DRC-IV lack the high affinity 
Mg++ binding at EF-2, perhaps Mg++ binding at EF-2 may be necessary for sequence-
specific DNA binding to DREAM, consistent with a structural role for Mg++ as proposed 
and studied in Chapter II.  
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Figure 4-20: EMSA (A) and SDS-PAGE (B) diagrams of DRC-I. Presence of 10 mM Ca++ is indicated at 
the bottom in panel A. (B) Stages during the purification of recombinant DRC-I protein. Molecular weight 








Figure 4-21: (A) EMSA and (B) SDS-PAGE diagrams of DRC-II. Presence of 10 mM Ca++ is indicated at 




Figure 4-22: (A) EMSA and (B) SDS-PAGE of DRC-III. Presence of 10 mM Ca++ is indicated at the 
bottom in panel A. Molecular weight markers from top represent 97, kda, 66, kda, 45 kda, 31 kda, 21 kda, 







Figure 4-23: (A) EMSA and (B) SDS-PAGE of DRC-IV. Presence of 10 mM Ca++ is indicated at the 






Figure 4-24: (A) EMSA and (B) SDS-PAGE of DRC-V. Presence of 10 mM Ca++ is indicated at the bottom 





Figure 4-25: (A) EMSA and (B) SDS-PAGE of DRC-VI. Presence of 10 mM Ca++ is indicated at the 
bottom in panel A. (B) Lanes- M: Molecular weight markers from top represent 97, kda, 66, kda, 45 kda, 




4.3.14 Structural Model for DNA binding to DREAM 
A structural model for DNA binding by DREAM can be proposed based on the x-ray 
crystal structure of calcium-bound KChIP1 and the data from this study (summarized in 
table 4-3). DREAM is thought to bind to DNA as a tetramer based on light scattering 
analysis of the DREAM-DNA complex [130] and apparent molecular mass on a 
Southwestern blot [74]. The Ca++-bound form of DREAM was shown to be a dimer in 
solution based on the work in Chapter 2.  The structure of the DREAM dimer can be 
estimated to have a head-to-tail orientation based on the x-ray structure of KChIP1 (Fig. 
4-8). A head-to-tail dimer orientation is also consistent with the size chromatography 
studies on the chimeras showing that each EF-hand is essential for dimer formation. We 
speculate that two DREAM dimers may come together and bind to DNA on opposite 
sides, perhaps by encircling it (fig. 4-26). This orientation enables all four EF-hands in 
the DREAM protein to contact DNA and would explain the apparent DNA binding 
observed for all the chimeras (Fig. 4-19). Calcium binding to the DREAM tetramer 
causes conformational changes that promote its dissociation into dimers and abolishes its 




Table 4-3: Summary of SEC results of DREAM-C, Recoverin and DRC’s I-VI. 
 
 
Figure 4-26: Model diagram showing potential assembly of a DREAM tetramer on the DNA. DREAM 
dimers, formed head-to-tail sideways similar to right and left hands joined with fingers against the palms of 
each other with the C-terminal helices projecting perpendicular to the plane of the palms, bind to DNA 
from either side thus assembling as a dimer of dimers formed head-to-tail again so that all the EF-hands 
make contact with the DNA.  
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4.4 Summary 
In summary, the calcium insensitive DNA binding to DREAM not withstanding, this 
study points to a DNA binding region in DREAM that encompasses all four EF-hands. 
However, these results must be interpreted with extreme caution, in view of the 
heterogeneous behavior of wild type DREAM protein. Therefore, the possibility of a 
localized DNA binding site still cannot be entirely ruled out. In the future, it will be 
necessary to test more rigorously which of the observed EMSA bands represent 
functional DREAM binding to DRE and to completely rule out any possible binding that 
could be induced by E. coli proteins co-purifying with DREAM. Experiments aimed at 
observing specific antibody supershift of the EMSA bands would be fruitful in this regard. 
In addition, inclusion of an additional purification step, size exclusion chromatography, 
to isolate DREAM protein samples to homogeneity and testing for their DNA binding 
activity may address the issue of spurious band shift, due to co-purifying E.coli proteins, 
rigorously. The other important issue is to resolve the discrepancy with earlier studies 
regarding the calcium dependence of the EMSA shift.  In this study, only a very small 
fraction of the protein (<10%) exhibits calcium-responsive DNA binding as was seen 
previously [74, 123].  The remainder of the protein in this study either binds DNA 
independent of calcium or in some cases binds DNA only in the presence of calcium.  
Clearly, the calcium-induced DNA binding is at odds with the earlier studies and is 
delineated from the calcium-sensitive binding, in this study.  The possibility exists, 
however, that the calcium-induced DNA binding might be functionally relevant and 
might explain a recent study showing that DREAM potentiates the activation of gene 
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expression regulated by the Vitamin-D receptor only at high Ca++ levels [125] and also 
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